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IMPACT OF 17-BETA ESTRADIOL AND MODERATE-INTENSITY EXERCISE ON
MESENTERIC ARTERIAL FUNCTION OF UC DAVIS TYPE-2 DIABETES MELLITUS
RATS
Abstract
By Md Rahatullah Razan
University of the Pacific
2021
The studies in this dissertation were designed to investigate the impacts of estrogen (17-β
estradiol/E2) and moderate-intensity exercise (MIE) on the mesenteric arterial (MA) function of
the University of California Davis type-2 diabetes mellitus (UCD-T2DM) Rat model. Our recent
report suggests that diabetes impairs MA vasorelaxation in both sexes of the UCD-T2DM model.
Particularly, we reported that MA from prediabetic male rats showed a greater impairment
compared to that in prediabetic females. However, when females become diabetic, they exhibit a
greater vascular dysfunction than males. Therefore, the aim of the first study was to investigate
whether female sex hormone, specifically E2, preserves the MA vasorelaxation in female UCDT2DM rats at the early prediabetic state. For this study, age-matched healthy Sprague Dawley
(SD) and prediabetic female UCD-T2DM rats were ovariectomized and subcutaneously
implanted with either a placebo or E2 pellet for 45 days.
Regular aerobic exercise is a well-known therapeutic intervention for endothelial
dysfunction, insulin resistance, and cardiovascular disease (CVD) risk in diabetes. However,
there are still debates about the duration, intensity, and underlying mechanisms of benefits of
exercise against deleterious metabolic consequences in diabetic patients. In the second study
outlined in this dissertation, we examined the impact of exercise training on vascular function
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and wall structure of the UCD-T2DM male rats. Age-matched male diabetic and SD control rats
were randomly divided into sedentary and exercise-trained groups. The exercise-trained groups
ran on a treadmill for eight weeks (1hr/day, 5days per week). For both studies (Studies I & II),
metabolic parameters and MA responses to vasodilator and vasocontractile agents were
determined. Furthermore, the expression of molecules associated with vascular signaling were
also analyzed.
The specific aims of our studies were to investigate whether E2 and moderate-intensity
exercise (MIE) alter the 1) endothelium-dependent vasorelaxation (EDV) and vasoconstriction 2)
relative contribution of endothelium-derived relaxing factors (EDRF) to vasorelaxation, and 3)
expression of proteins associated with vascular signaling, in MA of UCD-T2DM rats.
In the first study, we demonstrated that acetylcholine (ACh)-induced vasorelaxation was
impaired in MA of ovariectomized (OVX) prediabetic UCD-T2DM rats. Our data also showed
that E2 replacement improved MA relaxation in OVX prediabetic group to a similar level to that
in control groups. Inhibition of cyclooxygenase (COX) by indomethacin (Indo) did not
significantly affect the vascular responses in any groups, suggesting a minor role of COX
metabolites in MA relaxation in the experimental groups. Inhibition of nitric oxide (NO)
synthase (NOS) by L-NAME reduced vasorelaxation to ACh in control groups, but it did not
completely abolish the vasorelaxation. We also showed that in control (healthy) groups, both
NO and endothelium-derived hyperpolarizing factor (EDHF)-type relaxation were dominant in
the MA relaxation of placebo and E2 treated rats. However, in prediabetic groups, L-NAME
completely abolished the vasorelaxation, regardless of E2 treatment, suggesting a relative shift
from EDHF-type relaxation to only NO-mediated relaxation in these groups. Furthermore, the
sensitivity of MA to NO was significantly impaired in OVX prediabetic group, but E2 treatment
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enhanced the MA sensitivity to NO. Overall, our data suggest that a greater vasorelaxation in the
E2 treated OVX prediabetic group could be partly attributed to the elevated role of NO or
improved sensitivity of MA to NO in this group.
The second study demonstrated that ACh-induced vasorelaxation of MA was
significantly impaired in sedentary diabetic (DS) male rats. MIE significantly enhanced MA
vasorelaxation in the exercise-trained diabetic (DE) group compared to the DS. However, no
significant differences were observed between the vasorelaxation of control sedentary (CS) and
control exercise-trained groups (CE). Inhibition of COX enhanced maximal vasorelaxation
response (Rmax) to ACh in DS arteries suggesting an elevated contractile COX contribution in
MA of this group which could possibly be due to the observed increase in COX expression in the
DS group. Unlike the DS group, inhibition of COX did not affect the vasorelaxation responses
to ACh in the DE group. The addition of L-NAME resulted in a reduction in ACh-induced
relaxation of MA from both DS and DE groups. However, the effect of L-NAME was more
prominent in the DS group compared to the DE group, suggesting a major contribution of NO in
DS arteries. On the other hand, a preserved role of NO with an enhanced EDHF-mediated
relaxation was observed in the MA vasorelaxation of the DE group. Our data on the elevated
small conductance calcium-activated potassium channel (SKCa) expression level in MA taken
from the DE group compared to that in the DS group may suggest a role for SKCa in increased
EDHF-type relaxation in the DE group. Furthermore, DS arteries exhibited a higher contractile
response, myogenic tone, and wall thickness than those in MA of DE. Overall, our data suggest
that MIE reduced myogenic tone (DE vs. DS) and improved EDV in mesenteric arteries of
diabetic rats, possibly via a shift from contractile COX activity to both NO and EDHF-type
relaxation.
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In conclusion, the data generated in study-I suggest that estrogen may protect prediabetic
female MA from early vascular dysfunction, possibly by elevating the contribution of NO to
vasorelaxation as a compensatory mechanism to the loss of EDHF-type relaxation in this group.
Although the results of the current study are in agreement with our previous report demonstrating
a possible protective effect of female sex hormones in the MA function at prediabetic state,
additional studies are needed to establish the specific role of E2 in the progression of vascular
dysfunction in the diabetic state.
Lastly, an intriguing observation of study-II was that MIE improved vasorelaxation and
prevented the loss of EDHF-type relaxation in diabetic arteries. This was in addition to the
changes induced to the wall thickness and myogenic tone in arteries of UCD-T2DM males.
Given that sex differences play an important role in cardiovascular physiology, additional studies
are needed to establish the specific role of MIE on vascular dysfunction in UCD-T2DM female
rats and its underlying mechanisms.
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CHAPTER 1: INTRODUCTION

Cardiovascular diseases (CVD) are the leading causes of death for both men and women
in the United States (CDC, 2020b). However, the risk of CVD in diabetic men and women is
not similar. Although women suffer from fewer CVD events than men during premenopausal
years due to the cardioprotective role of female sex hormones, this sex difference is abolished in
menopause due to reduced estrogen level (Iorga et al., 2017). Premenopausal diabetic women
not only lose the sex-based protective effect but also have a higher relative risk of CVD than
diabetic men (Kannel & McGee, 1979). The transition of premenopausal women from a cardioprotective status to an increased CVD risk individual in diabetes is not well understood. Most
type-2 diabetic patients are obese, and obesity is associated with a significantly increased risk of
CVD in type-2 diabetes (T2D) (American College of Cardiology/American Heart Association
Task Force on Practice Guidelines, Obesity Expert Panel, 2013, 2014; Daousi et al., 2006).
Lifestyle modifications such as regular exercise and eating a balanced diet are at the forefront of
preventing obesity and T2D. Although exercise training is a proven method to prevent CVD and
diabetes, the type and intensity of exercise to improve vascular function in aging and diabetes
remain debated (Craighead et al., 2019).
1.1 Diabetes Mellitus
Diabetes is a metabolic disorder characterized by high blood glucose level and occurs
when pancreatic β-cells cannot produce enough insulin (type-1 diabetes) or when the body is not
responsive to insulin despite having a proper blood insulin level (T2D). According to National
Diabetes Statistics Report 2020, 34.2 million Americans have diabetes, and another 88 million
Americans have prediabetes. CVD remains the primary cause of hospitalization of patients with
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diabetes, and the total direct and indirect cost of diabetes was estimated at $327 billion in 2017
(Association, 2018).
1.1.1 Type-1 Diabetes (T1D)
T1D is also known as insulin-dependent diabetes mellitus. The initiation of type-1
diabetes occurs due to the destruction of insulin-producing pancreatic β-cells due to autoimmune disorder or environmental factors (such as viral infection). Therefore, the pancreas
produces little to no insulin and thus resulting in high blood glucose level. Type-1 diabetes
accounts for approximately 5-10% of the total diabetic patients in the USA.
1.1.2 Type-2 Diabetes (T2D)
T2D is the most common form of diabetes mellitus and accounts for 90-95% of the
diabetic patients. In T2D, the tissues become unresponsive to insulin which is known as insulin
resistance. Initially, the body counters insulin resistance by increasing insulin production from
pancreatic β-cells. However, over time overproduction of insulin exhausts β-cells and results in
diabetes mellitus. Genetic inheritance, together with lifestyle factors such as physical inactivity,
high fat diet, smoking, consumption of alcohol, are critical factors that could lead to type-2
diabetes (Ripsin et al., 2009).
1.2 Prediabetes
Before an individual develops type-2 diabetes, they almost always go through a phase
known as prediabetes. In prediabetes, the blood glucose level is elevated above the normal level
but not high enough to be considered diabetes. According to CDC, fasting glucose between 100125mg/dL or blood glucose level 140-199 mg/dL in glucose tolerance test or a HbA1c level
between 5.7-6.4% is considered prediabetes. Prediabetes is prevalent in obese individuals with
impaired glucose tolerance (Weiss et al., 2003). Approximately 88 million American adults have
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prediabetes which is about 1 in every 3 American adults. Prediabetes increases the risk of
developing type-2 diabetes and CVD (CDC, 2020a).
1.3 Diabetes and CVD
Cardiovascular risk is significantly higher in people with diabetes compared to nondiabetic individuals (Emerging Risk Factors Collaboration et al., 2010). Previous
epidemiological report suggests that diabetes is an independent risk factor for CVD in both men
and women and about 65% of the deaths in diabetic patients in due to some form of CVD
(Grundy et al., 1999). Both type-1 and type-2 diabetic patients suffer from increased burden of
CVD. However, since type-2-diabetes accounts for 90% cases of diabetes, most of the CVD
deaths occur from type-2 diabetes. Due to the masking effect of diabetes against CVD, many of
the symptoms remain undiagnosed and could be a reason for higher mortality in CVD in
diabetes.
Clustering of metabolic risk factors is commonly referred as metabolic syndrome.
Metabolic risk factors such as dyslipidemia, increased body weight, and abdominal obesity,
hypertension, insulin resistance increase both risk of diabetes and CVD (Rochlani et al., 2017).
Initiation of hyperglycemia in patients with metabolic syndrome accelerates the atherogenesis
probably by the initiation of endothelial dysfunction and increasing advanced glycation end
products. The injurious effect of hyperglycemia and metabolic syndrome on cardiovascular
system can be observed in both macrovascular (coronary artery disease, stroke, peripheral artery
disease) and microvascular (diabetic retinopathy, nephropathy, and neuropathy) levels (Fowler,
2008).
Microvasculatures with a relaxed diameter of less than 400µm are considered resistance
arteries. Resistance arteries, although small, are a major controller of systemic vascular
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resistance and blood pressure. For example, resistant mesenteric arteries (MA) and arterioles in
times of cardiogenic shock are responsible for 40% of the increase in systemic vascular
resistance (Ceppa et al., 2003). Thus, abnormalities in resistance arterial function have a
significant role in the pathogenesis of hypertension and other vascular diseases in diabetes
(Intengan & Schiffrin, 2000).
1.4 Endothelial Function
Vascular endothelium is the innermost layer of any vasculature that consists of a singlelayered endothelial cells. Although it consists of only a single layer of endothelial cells, a
healthy endothelium can respond to physical and chemical signals by producing a wide range of
factors which can modulate vascular tone, cellular adhesion, smooth muscle cell (SMC)
proliferation, and vessel wall inflammation. Therefore, impaired normal endothelial function,
otherwise known as endothelial dysfunction, can lead to CVD and is often described in diabetes,
hypertension, and atherosclerosis (Sun et al., 2019).
Endothelium-dependent vasorelaxation (EDV) is a reproducible parameter which can be
investigated to check vascular health in pathophysiological conditions. Impaired EDV is the
most common hallmark of endothelial dysfunction. To control the vascular tone, endothelium
produces vasorelaxant and contractile factors known as endothelium-derived relaxing factors
(EDRF) and endothelium-derived contractile factors (EDCF). EDRF is comprised of nitric oxide
(NO), prostacyclin (PGI2), and the elusive endothelium-derived hyperpolarization factor
(EDHF). On the other hand, EDCF includes endothelin-1 (ET-1), angiotensin-II, thromboxaneA2 (TXA2), etc. Endothelial dysfunction or impaired vasodilation can occur when there is
reduced production and sensitivity to EDRF, increased inactivation of EDRF, and/or increased
production and sensitivity to EDCF.
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Figure 1.1 EDRF and EDCF. Nitric oxide (NO) activates soluble guanylate cyclase, yielding
increased levels of cyclic GMP (cGMP). Prostacyclin (PGI2) activates adenylate cyclase, leading
to increased production of cyclic AMP (cAMP). The contribution of three mediators may differ
based on vascular bed. NO may predominate in large arteries, whereas EDHF takes over in smaller
blood vessels or in large arteries when the release of NO is curtailed. Depending on the species
and vascular bed studied, the identity of EDHF has been narrowed down to include
epoxyeicosatrienoic acids, K+ ions, H2O2, and the myoendothelial junctions. AA, arachidonic
acid; COX, cyclooxygenase; ECE, endothelin converting enzyme, NOS, NO synthase; L-Arg, Larginine; ETR, endothelin receptor; TP, thromboxane receptor; SKCa, small conductance calciumactivated potassium channels; IKCa, intermediate conductance calcium-activated potassium
channels.
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1.4.1 Nitric Oxide (NO)
NO is the most well studied vasodilator to date. It is a soluble gas that is usually
produced by nitric oxide synthase (NOS) from L-arginine in presence of oxygen (Tousoulis et
al., 2012). So far three isoforms of nitric oxide synthase have been identified: a) nNOS
(neuronal NOS; type I) b) iNOS (inducible NOS, type-II) c) eNOS (endothelial NOS, type-III)
(Förstermann & Sessa, 2012). These isoforms of NOS differ in their structure and function.
eNOS and nNOS are preferentially calcium-dependent enzymes, whereas iNOS is calciumindependent and stimulated in presence of inflammatory cytokines, bacterial lipopolysaccharide,
and other agents. eNOS is the most prominent of the NOS enzymes in the cardiovascular system
(Förstermann & Sessa, 2012).
Like all NOS, eNOS is a homo-dimer enzyme. Activation of eNOS occurs in presence of
stimuli such as insulin, vascular endothelial growth factor (VEGF), estrogen, bradykinin, and
fluid shear stress. Two important regulatory sites of eNOS phosphorylation are Serine 1177
(Ser1177) and Threonine 495 (Thr495), which are positive and negative regulatory sites
respectively. Depending on the stimuli, eNOS activation can occur through different pathways.
Bradykinin increases intracellular Ca2+ followed by phosphorylation of Ser1177 on eNOS by
Ca2+/calmodulin-dependent protein kinases II (CaMKII) whereas phosphorylation of eNOS by
estrogen happens through protein kinase B(Akt). Insulin can stimulate phosphorylation of eNOS
by both 5' adenosine monophosphate-activated protein kinase (AMPK) and Akt (Förstermann &
Sessa, 2012). Upon activation by phosphorylation, eNOS produces NO, which diffuses to the
underlying smooth muscle of the vasculature and activates soluble guanylyl cyclase (sGC) and
increases cGMP to relax vascular smooth muscle. Reduced activity of eNOS and/or increased
elimination of NO can be associated with the vascular dysfunction in diabetes. Under oxidative

29
stress, NO is scavenged by superoxide to produce peroxynitrite and thus reduce the
bioavailability of NO in the endothelium. Additionally, oxidative stress can cause eNOS
uncoupling, which preferentially produces superoxide instead of NO and further deteriorates the
oxidative stress in the vasculature (Förstermann et al., 2017; Radi, 2018).
Previous research has reported a wide range of biological activities of NO in the
cardiovascular system, including vasorelaxant, anti-platelet aggregation agent, and antiatherogenic, anti-inflammatory, angiogenic, anti-hypertrophic and other properties of NO
(Strijdom et al., 2009).
1.4.2 Prostacyclin (PGI2)
Prostaglandins (PG) were the first identified endothelium-derived vasoactive paracrine
substances. The most common precursor of prostaglandin is arachidonic acid which is released
from the cell membrane phospholipid by phospholipases. Cyclooxygenase (COX) enzymes
metabolize arachidonic acid to produce prostaglandin H2. Through the action of different
prostaglandin synthases, different types of vasoactive prostanoids such as PGI2, PGE2 PGF2α and
thromboxane are synthesized. There are two major isoforms of COX: COX-1 and COX-2
(Mitchell & Warner, 2006). COX-1 is constitutively expressed in most tissues, whereas COX-2
is induced in the presence of inflammatory stimuli. In a healthy blood vessel, both the
endothelium and to a lesser extent smooth muscle express both the COXs, but COX-1 remains
the predominant isoform. In most blood vessels, prostacyclin is the major metabolite of
arachidonic acid and described as a potent anti-aggregating agent and vasodilator. Generally,
PGI2 through its Gs-coupled receptor activates adenylyl cyclase and increases intracellular cyclic
adenosine monophosphate (cAMP). cAMP activates protein kinase A (PKA), which causes an
inhibitory effect on myosin light chain kinase (MLCK) and relaxes smooth muscle to cause
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vasorelaxation (Félétou et al., 2011; Raina et al., 2009). On the other hand, COX-derived EDCF
contribute to vascular dysfunction and CVD through stimulation of thromboxane receptor (TP)
(Félétou et al., 2011).
1.4.3 Endothelium Derived Hyperpolarization Factor (EDHF)
Besides NO and PGI2, endothelium can also control vascular tone by hyperpolarizing the
underlying smooth muscle. EDHF is more prominent in small resistance arteries compared to
large arteries and also an important regulator of vascular tone (Tomioka et al., 1999). The
contribution of EDHF on EDV and its identity could vary depending on the vascular bed under
question (Leo et al., 2011). Although the exact identity of EDHF is still not clear, a lot of
possible pathways have been suggested by previous research for the endothelium-dependent
hyperpolarization of smooth muscle (Edwards et al., 1998, 2010; Sandow Shaun L. et al., 2002).
In general, EDHF mediated response involves agonist-induced increase in endothelial cell Ca2+
concentration and subsequent opening of endothelial small conductance calcium-activated
potassium channel (SKCa) and intermediate conductance calcium-activated potassium channel
(IKCa). Two mechanisms have been proposed to explain SKCa and IKCa mediated smooth muscle
hyperpolarization. The first mechanism involves the opening of SKCa and IKCa channels and a
subsequent increase in potassium (K+) in myoendothelial space. An increase in K+ cloud in
myoendothelial space causes the activation of inward rectifier (Kir) and Na+/K+-ATPase pump in
the smooth muscle causing hyperpolarization of smooth muscle (Edwards et al., 1998;
Parkington et al., 2002; Sandow Shaun L. et al., 2002). The second mechanism involves the
transmission of endothelial hyperpolarization by direct electrical coupling through
myoendothelial gap junction (Edwards et al., 2010; Félétou & Vanhoutte, 2006). Another
mechanism, independent of SKCa and IKCa, has also been described where Ca2+ dependent
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release of epoxyeicosatrienoic acids (EET) and H2O2 from endothelium diffuse to smooth muscle
and hyperpolarize it (Félétou & Vanhoutte, 2006).
1.5 Sex Difference in CVD in T2D
Sex difference in CVD is well accepted (Miller, 2010). The lower rate of CVD in
premenopausal women compared to age-matched men has been attributed to the effect of female
sex hormones, specifically estrogen. Although adverse cardiovascular events in premenopausal
women are lower compared to men, women seem to lose their inherent sex-based protection
against CVD in diabetes (Barrett-Connor, 1994; Wilson et al., 1998). Furthermore, women are
at higher risk of CVD in diabetes compared to diabetic men. Framingham study showed that
symptomatic heart failure is 2.4 times higher in diabetic men and 5 times higher in diabetic
women compared to the non-diabetic cohort (Kannel et al., 1974). In a meta-analysis, Huxley et
al. reported that the risk of fatal coronary heart diseases is 50% higher in diabetic women
compared to diabetic men (Huxley et al., 2006). The underlying mechanism of higher CVD in
diabetic women and the role of sex hormone on female vascular function in T2D is poorly
understood.
1.6 Estrogen and Vascular Reactivity
Estrogen or Oestrogen is a category of female ovarian sex steroids. There are three major
endogenous estrogens: a) estrone b) estradiol c) estriol. Estradiol is more potent compared to the
other two major endogenous estrogens (Kuhl, 2005). Estrogen has many biological activities
that render its cardiovascular benefits, including lipid-lowering, antioxidant, fibrinolytic, and a
series of activities on the blood vessel. Vascular effect of estrogen occurs through both genomic
and non-genomic pathway through estrogen receptor (ER) mediated signal transduction. The
genomic regulation of estrogen has a delayed onset and prolonged duration of action, whereas
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the non-genomic action has a rapid onset and short duration of action. Classical genomic action
of estrogen occurs through interaction with intracellular ER-α and/or ER-β and is followed by
increased eNOS messenger ribonucleic acid (mRNA) translated in protein in the endothelial
cells. On the other hand, the non-genomic regulation of estrogen may be transduced through Gprotein coupled estrogen receptor (GPER1/GPR30) and a sub-family of membrane bound ER-α
and ER-β. Estrogen through the membrane ERs activates the phosphoinositide-3-kinase/protein
kinase B (PI3K/Akt) pathway and leads to eNOS activation by phosphorylation on Ser1177 site
(Duckles & Miller, 2010).
While many studies reported E2 might increase COX-mediated production of PGI2 in
endothelial cells (Khalil, 2010), contradictory reports of the impact of estrogen on COXmediated control of vascular tone are also present. Calkin et al. reported that E2 mediated rapid
cholinergic vasodilation in cutaneous vasculature is likely mediated by COX-2 pathway in
postmenopausal women (Calkin et al., 2002). On the contrary, Jiang et al. reported that E2
mediated vasorelaxation in rabbit coronary artery does not change in the presence of a nonselective COX inhibitor indomethacin, suggesting no role of prostanoids in E2 mediated
vasodilation in coronary artery (Jiang et al., 1991). Therefore, the effect of estrogen on COXmediated production of PGI2 may depend on vascular bed and species. It was also suggested,
estrogen may modulate the crosstalk between NOS and COX pathways where increased NOmediated vasorelaxation could decrease COX-mediated components of vasorelaxation (Case &
Davison, 1999).
Estrogen may play a significant role in controlling smooth muscle hyperpolarization and
vasorelaxation of small resistance arteries. It was reported that acetylcholine (ACh) induced
hyperpolarization in rat MA is higher in intact females and E2 replaced ovariectomized (OVX)
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females. In E2 deficiency, OVX female rat MA showed increased NO release but decreased
EDHF relaxation due to a reduction in gap junction proteins (Nawate et al., 2005). Therefore, it
was suggested that the contribution of EDRF may alter in female vasculature depending on
menopausal status.
1.7 Aerobic Exercise and Vascular Adaptation
Vascular effect of aerobic exercise may include structural or functional adaptation. The
physiological stimulus of aerobic exercise to cause these adaptations is repeated bout of
increased shear stress on the vascular endothelium. Endothelial shear stress is the tangential
force derived by the friction of flowing blood on the endothelium. The concept that shear stress
is the stimulus behind vascular adaptation is supported by different cell culture, animal, and
human studies (Chatzizisis et al., 2007; Green, 2009; Laughlin et al., 2004). Although evidence
suggests exercise training has a systemic effect on the arterial tree and enhance both conduit and
resistance arterial function and remodeling in human, however, no clear pattern emerges
regarding the impact of exercise training on different vascular beds (Padilla et al., 2011).
1.7.1 Shear Stress and Endothelial Function
Enhanced laminar shear stress in exercise training may help to improve vascular
endothelial function and prevent CVD by a number of possible mechanisms. Increased shear
stress in aerobic exercise could induce the release of several anti-atherogenic factors such as NO
and PGI2 which are not only well known EDRFs but also known for their inhibitory effect on
platelet aggregation, leukocyte migration, and SMC proliferation and inflammation (Traub &
Berk, 1998). Shear stress was also reported as an important inducer of EDHF mediated
vasodilation in rat mesenteric artery (Takamura et al., 1999).
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Shear stress is the most potent physiological stimulus that causes continuous production
NO from the endothelium. The shear stress mediated endothelial NO production could be
attributed to the activation of both genomic and non-genomic pathways. Increased NO
production by shear stress could occur through PI3K/Akt pathway mediated posttranslational
activation of eNOS by phosphorylation on Ser1179 site. Alternatively, shear stress could
increase NO production through enhancing eNOS gene expression in endothelial cells (Traub &
Berk, 1998). In arterial branches where shear stress is low or in areas of disturbed flow, NO
bioavailability may decrease due to reduced eNOS gene expression (Gambillara et al., 2006;
Harrison et al., 2006).
Shear stress may also lead to the production of another important EDRF and anti-platelet
aggregating agent, PGI2 (Frangos et al., 1985). It is believed that COX-2 is responsible for PGI2
synthesis in cardiovascular system, and thus selective inhibition of COX-2 explains the increased
atherothrombotic events. However, Kirkby et al. reported under physiological condition, COX1, but not COX-2, is responsible for PGI2 synthesis in both human and mouse aortic endothelial
cells using both static condition and under shear stress (Kirkby et al., 2012).
The shear stress could lead to activation of different mechanoreceptors present on the
endothelial cells such as the potassium channels. SKCa and IKCa were suggested to be involved
in shear stress mediated EDHF relaxation in rat MA (Takamura et al., 1999). Another important
smooth muscle hyperpolarizing factor, EET, was reported to be released from endothelium under
the influence of shear stress and hyperpolarize underlying smooth muscle in rodent gracilis
muscle artery and MA (Huang et al., 2005).
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1.7.2 Shear Stress and Vascular Wall Structure
Repeated bouts of shear stress by aerobic exercise can modulate vascular wall
characteristics. Low shear stress could reduce the production of NO and PGI2 and upregulate
ET-1 production and thus could lead to vascular atherosclerosis (Chatzizisis et al., 2007). Low
shear stress can induce both constrictive and expansive remodeling of coronary artery which
could lead to coronary atherosclerosis. Furthermore, reduced shear stress was reported to be
inversely related to intima medial thickness in carotid artery (Gnasso et al., 1996). Medial
thickness could be increased due to increase in extracellular matrix protein (elastin and collagen)
degradation by matrix metalloproteinases (MMPs) and SMC migration, differentiation, and
proliferation.
1.8 Rodent Model of Obesity and T2D
Metabolic diseases such as obesity, dyslipidemia, T2D and hypertension often occur in
combination. Many hereditary rodent models have been developed to study metabolic diseases
such as ob/ob mouse, db/db mouse, Goto-Kakizaki rat, Zucker diabetic fatty (ZDF) rat, Otsuka
Long-Evans-Tokushima-fatty (OLETF) rat, Spontaneously Diabetic Torii (SDT) rat, and
spontaneously hypertensive rat (SHR). In addition, in recent decades genetically modified
animals have also been added to the research of metabolic diseases. All the models added key
insights to our understanding of T2D and metabolic disorder. However, limitation remains as no
single individual model can potentially manifest all the key characteristics of T2D in human.
Although monogenic mutation is rarely the cause of human obesity and T2D, monogenic
rodent models are often used in T2D research. Although these models answered some important
questions in diabetes pathogenesis in human, they may not help us completely understand the
full spectra of the disease. Therefore, polygenic models are more appropriate in the study of
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obesity and diabetic condition in human. Several polygenic models of T2D are available such as
Goto-Kakizaki, OLETF rat, New Zealand obese (NZO) mouse. However, the problem with
majority of the polygenic rodent models is female animals do not develop diabetes or they
develop diabetes under conditions such as high-fat diet or environmental stress. GotoKakizaki
model, although resembles human T2D in several aspects, but unlike most human T2D patients
does not get obese. Goto-Kakizaki rat is an excellent model for studying non-obese human T2D.
OLETF rat model has a distinct mutation that causes little to no diabetes in female rats. NZO
mice model on the other hand, have very early obesity and poor fertility. Therefore, there is
increased urgency in developing a polygenic model that could manifest more of the human T2D
characteristics. Another recently developed versatile polygenic model is University of the
California Davis Type-2 Diabetes Mellitus (UCD-T2DM) Rat model. UCD-T2DM rat model
were generated by selectively breeding insulin resistant obese Sprague Dawley rat with ZDF lean
rat which had a defective β-cell function. UCD-T2DM shows adult onset-obesity, insulin
resistance, has preserved leptin function, fertility and develops T2DM on a low-fat, low-sugar
diet, and both sexes are affected (Kleinert et al., 2018). Hence UCD-T2DM represents an
etiology which is very similar to human T2D as shown in Table 1.1. However, the male and
female rats of UCD-T2DM model differ in their age of diabetic onset, with male being affected
earlier (4-8months) than females (8-12 months).
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Table 1.1
UCD-T2DM vs. ZDF Rat vs. Human T2D Comparison
Characteristics

UCD-T2DM

ZDF

Human T2D

Origin of obesity

Polygenic

Monogenic

Polygenic

Age of onset of T2DM

Males: ~183 days
Females: ~286 days

Males: ~60-90 days
Females: ~60 days on diet

Adolescent/Adult

Fertility

Preserved

Infertile

Preserved

Leptin function

Preserved

Deficient

Preserved

Plasma triglyceride

Moderate

Moderate

Severe

Adopted from (Cummings et al., 2008).
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1.9 Statement of Research Problems, Hypotheses, Objectives, and Innovation
It is now well known that men and women are different in the age-dependent onset of
CVD, severity, and symptoms. Premenopausal women exhibit lower incidence of CVD
compared to age-matched men. The reason behind the reduced CVD events in premenopausal
women compared to men is often attributed to the protective effect of the female sex hormone,
estrogen. However, premenopausal diabetic women not only lose the sex-based advantage
against CVD but also suffer from higher CVD-related events and mortality compared to men
(Kannel & McGee, 1979). The underlying mechanism(s) of the loss of sex-based protection and
the timeline for this loss in diabetes is not well understood.
T2D is often preceded by prediabetes. Prediabetes is characterized by a higher-thannormal blood glucose level but not too high enough to be classified as diabetes. Vehkavaara et
al. reported elevated fasting glucose in patients, although not as high as diabetes, may still induce
vascular dysfunction (Vehkavaara et al., 1999). Although several studies previously investigated
the underlying mechanisms by which vascular dysfunction occurs in diabetes, too little is known
about the vascular dysfunction at early prediabetic state, especially with regards to specific
effects of female sex hormones. Furthermore, currently to our knowledge, no study has
examined the impact of estrogen on vascular function in the prediabetic state, and whether
estrogen alters the contribution of EDRF (PGI2, NO, and EDHF) in vascular relaxation in this
state.
Based on our recent report (Shaligram et al., 2020) on sex disparity in the development of
MA dysfunction in prediabetic and diabetic UCD-T2DM rats, our central hypothesis for the first
study in this dissertation is that estrogen protects MA from vascular dysfunction in prediabetic
female rats. We further hypothesize that estrogen preserves EDV by enhancing the contribution
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of EDRF and/or decreasing the contribution of EDCF in UCD-T2DM prediabetic female rats.
Our aims were to test the hypotheses mentioned above by determining the effects of 17-β
estradiol replacement on the 1) vasorelaxation and contractile responses, 2) contribution of
EDRF to vasorelaxation, and 3) levels of expression of specific targets (i.e., eNOS, ER-α/β,
ΝADPH oxidases) which are associated with vascular signaling, in MA from OVX Sprague
Dawley (SD) and OVX prediabetic UCD-T2DM female rats.
Regular aerobic exercise is a proven method for intervening endothelial dysfunction,
insulin resistance, and cardiovascular risk in T2D (Okada et al., 2010). In addition, the effects of
exercise on vascularization, function, inflammation, and its metabolic consequences, including
diabetes and CVD, are also well identified (Disanzo & You, 2014; Ertek & Cicero, 2012;
Rodrigues et al., 2019). However, there is still debate about the intensity (moderate-intensity
aerobic exercise vs. high-intensity interval training) and type of exercise (i.e., aerobic or resistant
exercise) in preventing CVD in diabetes. Furthermore, underlying mechanisms of exercisemediated changes in diabetic vascular function and wall properties are poorly understood.
Previous report from our group suggests that the UCD-T2DM model exhibited an
impairment of MA vasorelaxation possibly, in part, due to a loss of EDHF-type relaxation.
However, whether exercise improves the MA vasorelaxation in male UCD-T2DM rats has not
been studied. Thus, our hypothesis (for the second study in this dissertation) was that moderateintensity aerobic exercise (MIE) induces beneficial effects on arterial function and structure,
possibly by altering the contribution of EDRF and/or EDCF on vasorelaxation and changing the
mechanical properties of the wall in MA from male UCD-T2DM rats. To test this hypothesis,
we aimed to investigate the effects of eight weeks of MIE on the 1) ACh-induced EDV and
vascular responses to contractile agents, 2) contribution of EDRF in vasorelaxation, 3)
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expression of proteins associated with NO-, COX-, and EDHF-mediated vasorelaxation and
vasoconstriction, and 4) pressure-induced change of myogenic tone, wall thickness and elastin
content in arteries (such as MA and aorta) isolated from male UCD-T2DM rats.
Since UCD-T2DM is an excellent model that imitates human T2D pathophysiology,
investigation of vascular dysfunction of this model could lead to novel mechanistic insights of
CVD in diabetes. Therefore, the innovation of this study lies in uncovering the contribution of
estrogen and moderate-intensity aerobic exercise on resistant MA changes in EDRF (PGI2, NO,
EDHF), wall structure, and myogenic tone in a novel rodent model of T2D.
Eventually, a better understanding of the mechanism of action of estrogen and exercise
on diabetic blood vessels could lead to sex-specific new therapeutic approaches to prevent higher
CVD events in diabetic and menopausal women.
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CHAPTER 2: STUDY I: 17β-ESTRADIOL (E2) IMPROVES ACH-INDUCED RELAXATION
OF MESENTERIC ARTERIES IN OVARIECTOMIZED UC DAVIS TYPE 2 DIABETES
MELLITUS (UCD-T2DM) RATS IN PREDIABETIC STATE.

2.1 Introduction
The prevalence of type-2 diabetes (T2D) is increasing at an alarming rate worldwide
(Zheng et al., 2018). Cardiovascular diseases (CVD) are the primary cause of death and
disability in diabetic patients (Einarson et al., 2018). It is now well established that sex
difference exists in CVD onset, severity, and outcomes (Miller, 2010). The prevalence of CVD
in premenopausal women is less than age-matched men. The female sex hormone, estrogen in
particular, plays a role in the sex-specific cardiovascular protection in women (Barrett-Connor,
1994; Iorga et al., 2017). Several studies including ours suggest that diabetes affects male and
female vascular bed differently (Akther et al., 2021; Lum-Naihe et al., 2017; Shaligram et al.,
2020; Witcher et al., 2010; Zhang et al., 2012). Diabetes not only abolishes the female-specific
cardiovascular protection but also increases the relative events of CVD in premenopausal
diabetic women compared to diabetic men (Castro’, n.d.; Peters et al., 2015), suggesting that
hyperglycemia may overcome some of the beneficial effects of female sex hormones. However,
the timeline of the loss of female-speciﬁc cardiovascular protection in diabetic premenopausal
women is not well understood.
An appropriate animal model may provide critical insights into the pathogenesis of
cardiovascular dysfunction in T2D. The current study was performed in mesenteric arteries
(MA) of a polygenic T2D rat model, the UC Davis type-2 diabetes mellitus (UCD-T2DM) rat.
This model exhibits polygenic adult-onset obesity, insulin resistance, pancreatic beta-cell
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decompensation, and preserved leptin signaling and fertility (Cummings et al., 2008). We
recently reported sex difference exists in the MA function of UCD-T2DM as early as the
prediabetic state (Shaligram et al., 2020). Specifically, vasorelaxation to acetylcholine (ACh)
was impaired to a greater extent in MA from males than in females at the prediabetic state. In
contrast, the arteries from diabetic females exhibited a greater impairment to ACh-induced
vasorelaxation when compared with the diabetic males. Here, we hypothesized that estrogen
might be responsible for delaying vascular endothelial dysfunction in prediabetic females.
Thus, in the current study, we investigated the effect of 17-β estradiol (E2) administration on the
MA function of ovariectomized (OVX) rats both at healthy and prediabetic states.
Endothelial dysfunction is considered a critical early sign of CVD. Endotheliumdependent vasorelaxation (EDV) can be used as a reproducible parameter to examine endothelial
function and vascular health. Reduced EDV was reported in both type-1 and type-2 diabetes
(Han et al., 2014; Shaligram et al., 2020; Zhang et al., 2012). Altered EDV could result from
reduced release and/or synthesis of endothelium-derived relaxing factors (EDRF) [nitric oxide
(NO), prostacyclin (PGI2), and endothelium-derived hyperpolarization factor (EDHF)] and/or
increased production of endothelium-derived contractile factors (EDCF) [i.e., thromboxane A2
(TXA2) and endothelin (ET-1)].
The contribution of EDRF to EDV may vary based on the vascular bed. While in large
conduit arteries, NO is the major contributor for vasorelaxation, in small resistance arteries,
EDHF was found to be the major contributor for EDV (Félétou, 2011; Zhang et al., 2012).
Previous reports from our group suggest diabetes alters NO and EDHF contribution in both large
and small resistance arteries and a reported sex difference in vascular function of UCD-T2DM
(Akther et al., 2021; Shaligram et al., 2020; Zhang et al., 2012). However, whether the observed
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sex difference in vascular function was due to the influence of sex hormones, was not
investigated. Among male and female sex hormones, estrogen has a pronounced effect on
vasculature. Receptor-mediated estrogen signaling could increase genomic transcription of
endothelial nitric oxide synthase (eNOS) as well as increase eNOS activation via
phosphoinositide-3-kinase/protein kinase B (PI3K/Akt) pathway (Duckles & Miller, 2010).
Estrogen was also reported to increase EDHF-type relaxation in mesenteric and uterine
resistance arteries (Burger et al., 2009). However, the specific role of estrogen on NO and
EDHF contribution in MA relaxation at the prediabetic state was not investigated.
This study demonstrates that E2 replacement improved MA vasorelaxation in
ovariectomized rats at prediabetic state. Here, we provide the first evidence of the specific role
of E2 in protecting MA from early vascular dysfunction in female prediabetic UCD-TDM rats.
2.2 Materials and Methods
2.2.1 Chemicals
All chemicals were purchased from either Fisher Scientific (Waltham, MA) or Sigma
Aldrich (St. Louis, MO, USA) and dissolved in water unless otherwise stated.
2.2.2 Experimental Animals:
The UCD-T2DM rats were generated by selectively breeding obese Sprague Dawley
(SD) rats with Zucker Diabetic Fatty (ZDF) lean rats at the animal facility in the Department of
Nutrition at the UC Davis (Cummings et al., 2008). This model closely resembles human T2D
and shows polygenic adult onset of diabetes, preserved fertility, and leptin function, and has
inherent dysfunction of pancreatic β-cell (Cummings et al., 2008, 2011).
For this study, we selected 13-14-weeks-old female UCD rats that had not yet developed
diabetes (prediabetic group) but had higher body weight than controls. Furthermore, they were
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considered prediabetic when the blood glucose readings of animals were in the range of 150200mg/dl (Guglielmino et al., 2012). These prediabetic female rats were then surgically
ovariectomized (OVX) and implanted subcutaneously with either E2 (1.5mg 17β-estradiol/pellet,
60-days uniform release) or placebo pellet (Innovative Research of America, Sarasota, FL).
Similarly, age-matched and OVX SD females implanted subcutaneously with E2 or placebo
pellets were purchased from Charles River Laboratories (Wilmington, MA). In general, animals
were divided into four experimental groups: (1) OVX + placebo [OVX], (2) OVX + E2, (3)
prediabetic OVX + placebo [PD OVX], (4) prediabetic OVX + E2 [PD OVX+E2]. After pellet
implantation, both prediabetic and SD rats stayed at their respective facility (UC Davis and
Charles Rivers) for one week. The rats were later transferred to animal facility at the University
of the Pacific.
All the animals at the University of the Pacific vivarium were kept in a humidity and
temperature-controlled room with a 12hrs light/dark cycle and ad libitum access to water and
standard rodent chow (Mazuri rodent chow). The animals were euthanized using carbon dioxide
at 49±4 days after the implantation of the pellets. The euthanasia processes were completed
following AVMA Guidelines for the Euthanasia of Animals: 2013 edition and the NIH
Guidelines for the Care and Use of Laboratory Animals: Eighth Edition. In addition, all animal
protocols were approved by the Institutional Animal Care and Use Committee of the University
of the Pacific and UC Davis and complied with the Guidelines for the Care and Use of
Laboratory Animals: Eighth Edition (National Research Council (US) Committee for the Update
of the Guide for the Care and Use of Laboratory Animals, 2011) and ARRIVE guidelines
(Kilkenny et al., 2010).
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2.2.3 Blood and Plasma Analysis
A drop of blood from the tail vein was used to measure random blood glucose and
triglyceride level by hand-held point of care devices. Glucose levels were measured by a
standard glucometer (OneTouch UltraMini) and, triglyceride levels were measured by Accutrend
Plus System (Roche Farma, Barcelona, Spain) using specific strips for each device.
Blood samples were also obtained by intracardiac puncture after euthanizing the animals
and collected in tubes containing heparin and sodium citrate. The tubes were then centrifuged at
10000xg for 5min at 4°C, and plasma was collected from the top and aliquoted into fresh tubes
to be stored at -80°C for later analysis. Plasma insulin and E2 level were measured using ELISA
kits according to the manufacturer's protocol (Mercodia, Uppsala, Sweden; Abcam, Cambridge,
MA). In addition, blood collected by intracardiac puncture was also used for glycated
hemoglobin (HbA1c) level analysis using A1cNow kit (PTS diagnostics, Sunnyvale, CA) and
following the manufacturer's instructions.
2.2.4 Measurement of MA Tension
Third-order MA branches were isolated and cleared from veins, fat, and other
surrounding tissues and cut into 2mm rings. Each ring was then mounted in an organ bath,
between the two jaws of a wire myograph (model 610M, Danish Myo Technology, Denmark)
with the help of two tungsten wires (diameter 40µm). The organ bath contained Krebs solution
of (in mM) 119 NaCl, 4.7 KCl, 1.6 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 25 NaHCO3, 0.023 EDTA,
and 6 glucose at 37°C, bubbled with 95% O2–5% CO2. A computer-based data acquisition
system was used to monitor the arterial tension (LabChart version 7.3.8, Powerlab;
ADInstruments, Colorado Springs, CO). The arterial rings were normalized to a resting tension
of 13.3KPa and equilibrated for 30 mins to obtain a basal tone. 80mM KCl solution was then
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used twice to stimulate the arterial segments. Subsequently, ACh (10µM) induced relaxation
was recorded in phenylephrine (PE, 2µM) precontracted arteries to test the viability of the
endothelium.
2.2.4.1 Relaxation Responses to Ach
MA rings were contracted with PE 2µM, which produced about 80% of the maximal
contraction. Increasing doses of ACh (10-8 to 10-5 M) were added to PE precontracted MA rings
to obtain the concentration response curve (CRC).
The vascular relaxation responses to ACh (10-8 to 10-5 M) in rat MA rings were then
obtained after 20 mins pretreatment with indomethacin (Indo, 10 µM, a blocker of the
cyclooxygenase (COX)), followed by the addition of Nw-nitro-L-arginine methyl ester ( LNAME, 200 µM, NO synthase (NOS) blocker) and then a combination of Apamin [1 µM, small
conductance calcium-activated potassium channel (SKCa) inhibitor] and TRAM-34 [1 µM,
intermediate conductance calcium-activated potassium channel (IKCa) inhibitor].
2.2.4.2 Relaxation Responses to Sodium Nitroprusside (SNP)
The CRC to SNP (10-9 to 10-5 M) was obtained in MA precontracted with PE (2µM).
2.2.4.3 Contractile Responses to PE
The CRC to PE was obtained by the addition of increasing concentrations of PE (10−8 to
10−5 M) to the organ bath. The concentration of drugs used to generate relaxation or contraction
curves was based on the standard protocol used by our group (Han et al., 2014; Shaligram et al.,
2020; Zhang et al., 2012).
2.2.5 Western Blot Analysis
All tissue samples harvested after euthanizing the animals were flash-frozen by liquid
nitrogen and saved at -80°C for later analysis. MA and skeletal muscle (SKM) samples were
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micronized either using gentleMACs tissue dissociator (Miltenyi Biotech, Bergisch, Germany)
and following preset protocol for protein extraction or micronized by freezing with liquid
nitrogen and grinding with a mortar and pestle as previously described (Baena et al., 2015). For
both processes, commercial RIPA buffer supplemented with phosphatase and protease inhibitor
cocktail (ThermoFisher Scientific, Waltham, MA) was used to obtain the total protein extract
from the tissues. Briefly, for processing by gentleMACs tissue dissociator, tissues were placed
in M-tubes (Miltenyi Biotech, Bergisch, Germany) containing RIPA buffer, phosphatase, and
protease inhibitor cocktail. Protein extraction protocol was selected from the gentleMACs menu,
and after 1 min, the blended tissue extract was centrifuged at 15000xg for 15 min at 4°C, and
supernatants were collected. When the gentleMACs tissue dissociator was not available, MA
samples were micronized under liquid nitrogen to obtain total protein extract. The powdered
MA were then put in tubes containing RIPA buffer and phosphatase and protease cocktail and
incubated for 1.5h at 4°C. Finally, the mixtures were centrifuged at 15000xg for 15 min at 4°C,
and supernatants were collected. Total protein concentration of the extract was determined by
BCA gold assay (ThermoFisher Scientific, Waltham, MA).
20-30µg of protein for each sample was subjected to sodium dodecyl sulfatepolyacrylamide gels electrophoresis (SDS-PAGE). Proteins were then transferred to a 0.45 μm
nitrocellulose membranes (Bio Rad Laboratories Inc., Hercules, CA), blocked for 1 h at room
temperature with 5% w/v BSA in 0.1% Tween 20-Tris-buffered saline, and incubated overnight
at 4°C with primary antibodies similarly as described by us (Akther et al., 2021). Primary
antibodies for eNOS, AMP-activated kinase-α (AMPK-α), phospho-AMPK-α (p-AMPK-α,
Thr172), and insulin receptor substrate-1 (IRS1) were obtained from cell signaling technology
(Danvers, MA) and antibodies against estrogen receptor-β (ER- β), NADPH oxidase-1 (NOX-1),
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glucose transporter-4 (GLUT-4) were obtained from Abcam (Cambridge, MA). All primary
antibodies were diluted to 1:1000 except IRS-1, which was diluted to 1:500. After incubation
with primary antibody, the membranes were washed 4 times and incubated for 1hr at room
temperature with IRDye 680 Donkey anti-Rabbit IgG secondary antibody (dilution 1:10000; LICOR, Lincoln, NE). Finally, after removing the secondary antibody, membranes were washed 4
times with TBS containing 0.1% Tween-20, and bands were detected using the LICOR Odyssey
imaging system. The bands were quantified by densitometry using LI-COR Image Studio Lite
software. To confirm the uniformity of protein loading, blots were incubated with GAPDH
antibodies, normalized to GAPDH level, and expressed as fold changes from the control E2
treated group.
2.2.6 Statistical Analysis
Vasodilation to ACh and SNP were expressed as percent relaxation response from
maximum PE (2µM) contraction at each concentration. The concentration that produces half of
the maximum relaxation (EC50) was calculated by a sigmoidal dose-response model with
variable slope by GraphPad Prism 8.0 (GraphPad Software, San Diego, CA) and expressed as
sensitivity to the agonist; pD2 values (-logEC50). Maximum relaxation response to agonist was
expressed as Rmax, and maximum tension to contractile agent such as PE was expressed as
Tensionmax. One-way ANOVA was used to compare the means between different groups (i.e.,
EC50, Rmax, Blood glucose level). When one-way ANOVA returned P<0.05, Tukey’s post hoc
test was used to identify the groups which are different from each other. Comparison of CRCs
between different groups were done by two-way ANOVA followed by Tukey’s post hoc test.
Two-way ANOVA with repeated measures followed by Bonferroni’s post hoc analysis was used
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to compare the CRCs before and after treatment with drugs within a group. Statistical analysis
of protein expression was performed by one-way ANOVA and Tukey’s post hoc analysis.
2.3 Result
2.3.1 Effects of E2 Treatment on Metabolic Parameters
E2 pellets significantly increased the concentrations of plasma estradiol (Figure 2.1A). E2
concentrations were significantly lower in OVX, and PD OVX rats than those in respective E2
treated OVX rats. In agreement with Ferrer et al. and our previous report (Ferrer et al., 1996;
Rahimian et al., 1997), the body weights of E2 treated rats were significantly lower than those of
non-treated rats at the time of euthanizing the animals. The body weight was 348.0±9.0 g in
OVX and 218.2±5.9 g in OVX + E2, and 444.3±11.3 g in PD OVX, and 323.0±16.6 g in PD
OVX + E2. Similar to body weight, the percent of intra-abdominal adipose tissue (located
around mesentery and omental) was significantly lower in E2 treated OVX and PD OVX groups
(Figure 2.1F). Both body weights and abdominal adiposity in E2 treated OVX groups were
comparable to their respective intact SD female and prediabetic female rats in our previous
report (Shaligram et al., 2020).
Compared to E2 treated groups, the PD OVX group had a significantly higher glucose
level (Figure 2.1C). Accordingly, HbA1c, plasma insulin, and triglyceride levels were
significantly higher in the PD OVX group compared to all other experimental groups (Figure
2.1D, E, G).
2.3.2 Effects of E2 Treatment on IRS1 and GLUT-4 Expression in SKM
The SKM is the major site for insulin-mediated glucose uptake. Although β-cell failure
is a common characteristic of T2D, SKM insulin resistance and reduced glucose clearance are
considered the initiating factors leading to overt hyperglycemia and β-cell dysfunction
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(DeFronzo & Tripathy, 2009; Warram et al., 1990). Higher glucose and HbA1c levels, together
with higher insulin level in the PD OVX group (Figure 2.1C, D, E), prompted us to analyze the
expression of the primary insulin signal transducer, IRS1, and GLUT-4 in SKM. As shown in
Figure 2.2A, IRS1 expression in SKM was significantly lower in the PD OVX group compared
to the OVX and OVX+E2 groups. There was no difference in IRS1 expression in the SKM of
OVX and OVX +E2. E2 treatment increased IRS1 in SKM of the PD OVX group, although the
difference did not reach to a significant level. When GLUT-4 expression was investigated, both
the PD OVX and OVX groups showed significantly lower expression compared to the respective
E2 replaced group, regardless of the disease state (Figure 2.2B).
A previous report also indicates that E2 may activate AMPK leading to an increase in
glucose uptake in SKM in C57 BL/6 mice (D’Eon et al., 2005). Next, we investigated whether
AMPK and phospho-AMPK (p-AMPK) levels in SKM were altered in E2 treated groups. E2
treatment significantly increased AMPK and p-AMPK levels in SKM (0.8- and 0.7-fold
respectively) only in the PD OVX group compared to the respective E2 treated control group
(Figure 2.3 A-B).
2.3.3 Effects of E2 Treatment on Relaxation Responses to ACh
ACh (10-8 –10-5 M) concentration-dependently relaxed PE-precontracted MA rings.
There was no significant difference in ACh-induced relaxation in MA rings from OVX rats
compared with those from OVX + E2 rats, as indicated by no significant differences between
Rmax and pD2 values of the OVX and OVX+E2 CRCs to ACh (Figure 2.4 Table 2.2). However,
the ACh CRC was markedly impaired in MA of the PD OVX group compared to those in OVX
and OVX+E2 groups (Figure 2.4). Both the Rmax and PD2 values were significantly lower in the
MA of the PD OVX group when compared to the OVX and OVX+E2 groups (Table 2.2).
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However, E2 treatment significantly enhanced the Rmax and PD2 to ACh in the PD OVX rats to
the same level as seen in MA of OVX or OVX + E2 (Figure 2.4, Table 2.2).
2.3.4 Effects of E2 Treatment on the Relative Contribution of EDRF to MA Relaxation
The relative contribution of PGI2, NO, and EDHF to vasorelaxation induced by ACh
were determined by sequentially blocking COX, NOS, and a combination of SKCa and IKCa
channels. Specifically, EDV to ACh (10-8 to 10-5 M) in rat MA rings precontracted with PE (2
µM) was obtained before and after pretreatment with Indo (10 µM), followed by the addition of
L-NAME (200 µM) and then a combination of apamin (1 µM) and TRAM-34 (1 µM). The
administration of Indo did not significantly change the ACh CRC in any of the groups when
compared to no drug ACh CRC (Figure 2.5A-D). The addition of L-NAME significantly
reduced the ACh relaxation in OVX and OVX+E2 groups but did not completely block the
relaxation. After the addition of L-NAME, the Rmax to ACh was 75.3±9.4% in OVX and
96.7±1.4% in OVX + E2 rats (Table 2.3). The remaining area under the curve (AUC) after the
addition of L-NAME in the OVX and OVX + E2 groups suggests a role of PGI2-NO-independent
relaxation responses in these groups. Finally, pretreatment of MA with apamin and TRAM-34 in
the presence of Indo and L-NAME completely abolished the remaining ACh-induced
vasorelaxation in these groups (Figures 2.5A-B)
On the other hand, after the addition of L-NAME, the ACh-induced relaxation was
completely abolished in prediabetic groups, regardless of E2 treatment (Figure 2.5C-D).
However, the effect of L-NAME was more prominent in the E2-treated prediabetic group
compared with their respective control (OVX+ E2) group. Specifically, ΔAUC between Indo
and Indo+L-NAME CRCs in the PD OVX + E2 group was significantly different from the
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OVX+ E2 and PD OVX group, suggesting an elevated role of NO-dependent relaxation
responses in this group (Table 2.3, Indo+L-NAME column; Figure 2.5D, Pink shaded area)
2.3.5 Effects of E2 Treatment on SNP-induced Relaxation
The MA sensitivity to NO was assessed by measuring the relaxation responses to
increasing concentration of SNP (10-9 to 10-5 M). Similar to the effects on ACh-induced
endothelium-dependent relaxation, SNP-induced relaxation was significantly impaired in PD
OVX compared to that in MA of the OVX group. The pD2 values to SNP were 6.59 ± 0.2 in
OVX, and 3.6 ± 0.2 in PD OVX animals. The Rmax to SNP in OVX and PD OVX animals was
86.6±3.0% and 19.1±4.3%, respectively. E2 treatment enhanced the pD2 and Rmax to SNP in both
OVX and PD OVX rats (Figure 2.6, Table 2.4). However, there was still a significant, rightward
shift of SNP CRC in MA from PD OVX+E2 rats relative to OVX+E2 (Figure 2.6), as assessed by
both pD2 values and Rmax. The pD2 values to SNP was 8.17±0.2 in OVX+E2, and 5.49±0.6 in
PD OVX+E2 animals. The Rmax to SNP in OVX+E2 and PD OVX+E2 animals was 101.7±0.6%
and 57.68±7.5%, respectively.
2.3.6 Effects of E2 Treatment on PE-induced Contraction
Next, we examined whether an elevated contractile response of the arteries was
responsible for reduced ACh and SNP relaxation in the PD OVX group. We determined the
specific effects of E2 treatment on contractile responses. Therefore, the CRCs to PE (10-8 to 10-5
M) were compared in MA among experimental groups (Figure 2.7). As shown in table 2.5, the
maximum contractile response to PE (Tensionmax) but not the sensitivity to PE was higher in MA
of PD OVX and PD OVX+E2 when compared to that in OVX and OVX+E2. Furthermore, our
data shows that E2 treatment did not affect vasoconstrictor responses to PE, irrespective of the
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health or disease status. There were no significant statistical differences in MA PE sensitivity
(pD2) and Tensionmax between OVX and OVX+E2 or PD OVX and PD OVX+E2.
2.3.7 Effects of E2 Treatment on ER, eNOS and NOX-1 Expression
Previous reports, including ours (Thor, Zhang, et al., 2010) have shown that the vascular
effects of E2 are mediated via ER subtypes, and in part by augmenting the function of eNOS.
Thus, next we analyzed the expression of ER in MA of our experimental groups, using Western
blot analysis. There was no difference in ER-α expression between OVX and PD OVX groups
regardless of E2 treatment (Figure 2.9). However, ER-β expression significantly (~0.5 fold)
increased the in PD OVX+E2 groups when compared to that in PD OVX group (Figure 2.8 Β).
To investigate the possible mechanisms underlying the elevated contractile responses (or
decreased ACh responses) in PD OVX model, the protein expression of eNOS as well as
NADPH oxidase (NOX) subtypes NOX-1, major source of superoxide in the small vessel wall
arteries (Touyz et al., 2002) in MA were measured. Western blot analysis revealed that the
expression of eNOS showed no significant difference between the PD OVX group and the OVX
group, regardless of E2 treatment (Figure 2.8A). However, as shown in Figure 2.10, NOX-1
expression was significantly elevated in MA tissues from PD group, ~6 fold in PD OVX and
~3.5 fold in PD OVX + E2 compared with those in OVX and OVX + E2. Although, the NOX-1
expression tended to be lower in PD OVX+E2 than in PD OVX, the difference was not
statistically significant.
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Figure 2.1 Metabolic parameters of ovariectomized and E2 replaced SD control and
prediabetic rats. (A) Plasma estradiol (E2) concentration (B) Body weight (C) Blood
glucose level (D) HbA1c (E) Plasma insulin level (F) Abdominal adipose tissue percentage
to total body weight (G) Circulating triglyceride level (H) Plasma nitrate and nitrite level.
Values are represented as mean ± SEM. Each bar represents the values obtained from
n=5-6 animals per group. Capped lines indicate significant differences between two groups
(*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001), analyzed by one-way ANOVA
followed by Tukey’s post hoc test.
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(Figure 2.1 Continued)
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Table 2.1
Metabolic Parameters of Ovariectomized and E2 Replaced SD Control and Prediabetic Rats
OVX

OVX+E2

PD OVX

PD OVX+E2

Body Weight (g)

348.0±9.0

218.2±5.9#

444.3±11.3*#

323.0±16.6*$

Blood Glucose (mg/dl)

153.8±6.2

129.6±13.1

182.3±12.9*

131.5±8.3$

HbA1c (%)

4.47±0.1

4.0±0.0

5.80±0.2*#

4.31±0.1$

Abdominal Adipose
Tissue (%)

3.94±0.6

2.08±0.3#

5.95±0.4*#

2.63±0.4$

Triglyceride (mmol/l)

2.2±0.2

2.85±0.3

5.45±0.3*#

1.93±0.3$

Plasma E2 level (pg/ml)

4.47±1.1

58.08±18.8#$

1.60±0.5

49.27±12.6#$

Insulin (ng/ml)

1.25±0.2

1.34±0.2

2.98±0.3*#

1.3±0.1$

Plasma
Nitrite+Nitrate (µM)

4.07±0.9

2.68±0.4

14.6±2.3*#

3.3±0.9$

Data are expressed as mean ± SEM; n=5-6 rats per group. #p<0.05 (vs. OVX), *p<0.05 (vs.
OVX+E2), $p<0.05 (vs. PD OVX), analyzed using one-way ANOVA followed by Tukey’s post
hoc test.
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Figure 2.2 Western blot analysis of (A) IRS1 (B) GLUT-4 expression in skeletal muscle of
ovariectomized and E2 replaced SD control and prediabetic rats. Protein level were quantified by
densitometry and normalized to corresponding GAPDH. Values are represented as mean ± SEM.
Each bar represents the values obtained from n=4-5 animals per group. Representative bands of
target and housekeeping protein (GAPDH) were shown from the same membranes. Capped lines
indicate significant differences between two groups (*p<0.05, **p<0.01, ***p<0.001), analyzed
using one-way ANOVA followed by Tukey’s hoc test.
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Figure 2.3 Western blot analysis of (A) AMPK-α (B) p-AMPK-α expression in skeletal muscle of
ovariectomized and E2 replaced SD control and prediabetic rats. Protein level were quantified by
densitometry and normalized to corresponding GAPDH. Values are represented as mean ± SEM.
Each bar represents the values obtained from n=4-5 animals per group. Representative bands of
target and housekeeping protein (GAPDH) were shown from the same membranes. Capped lines
indicate significant differences between two groups (*p<0.05, **p<0.01), analyzed using one-way
ANOVA followed by Tukey’s hoc test.
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Figure 2.4 Relaxation responses to cumulative concentrations of acetylcholine (ACh, 10-8 to 10-5
M) in intact mesenteric arterial rings precontracted with phenylephrine (PE, 2µM) from
ovariectomized and E2 replaced SD control and prediabetic rats. Data are expressed as mean ±
SEM. n=5-6 animals per group. Parenthesis indicates significant differences between groups (*p<
0.05) analyzed using 2-way ANOVA followed by Tukey’s post hoc test.
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Table 2.2
Sensitivity (pD2: -logEC50), and Maximum Response (Rmax) to ACh in Mesenteric Arteries from
Ovariectomized and E2 Treated SD Control and Prediabetic Rats
ACh

n

pD2(-logEC50)

Rmax (%)

OVX

6

7.1±0.05

99.75±0.27

OVX+E2

5

7.1±0.03

100.1±0.1

PD OVX

6

2.5±0.9*#

41.77±5.66*#

PD OVX+ E2

6

6.8±0.07$

91.06±3.93$

Data are expressed as mean ± SEM; n=5-6 rats per group. #p<0.05 (vs. OVX), *p<0.05 (vs.
OVX+E2), $p<0.05 (vs. PD OVX), analyzed using one-way ANOVA followed by Tukey’s post
hoc test.
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Figure 2.5 Effects of inhibiting cyclooxygenase, nitric oxide synthase, small conductance and
intermediated conductance calcium-activated potassium channels (SKca and IKca) on acetylcholine
(ACh)-induced vasorelaxation in mesenteric arteries taken from ovariectomized and E2 replaced
SD control and prediabetic rats; (A) OVX (B) OVX+E2 (C) PD OVX (D) PD OVX+E2.
Concentration response curve (CRC) to ACh (10-8 to 10-5) was generated in the presence of no
inhibitor (No drug) or in the presence of Indo, Indo+L-NAME (I+L), and Indo+LNAME+Apamin+TRAM-34 (I+L+A+T) in mesenteric arterial rings. Indo (indomethacin; 10µM),
L-NAME (Nw-nitro-L-arginine methyl ester; 200µM), Apamin (1µM), TRAM-34; [1-[(2Chlorophenyl)diphenylmethyl]-1H-pyrazole; 1µM]. * (P<0.05) vs. no drug; # (P<0.05) vs. Indo;
$ (P<0.05) vs. Indo+L-NAME, analyzed using 2-way ANOVA with repeated measures followed
by Bonferroni post hoc test.

Data are expressed as mean ± SEM; n=5-6 rats per group. Analysis between group: #p<0.05 (vs.OVX), *p<0.05 (vs. OVX+E2),
$p<0.05 (vs. PD OVX), analyzed using one-way ANOVA followed by Tukey’s post hoc test. Analysis within group: ap<0.05
vs. no drug control within each group, bp<0.05 vs. indo within each group (paired Student’s t-test). ND; not determined.

A comparison of sensitivity (pD2), maximum response (Rmax) and ΔAUC to acetylcholine in the absence (no drug) or in the
presence of Indo, Indo+L-NAME, and Indo+L-NAME+Apamin+TRAM-34in MA rings from mesenteric arteries taken from
ovariectomized and E2 replaced SD control and prediabetic rats. ΔAUC were measured by measuring the area between two
curves. ΔAUC of Indo indicates COX contribution, ΔAUC of Indo+L-NAME indicates NO contribution and, ΔAUC of Indo+LNAME+Apamin+TRAM-34 indicates EDHF-type contribution in ACh-induced vasorelaxation of MA.

Table 2.3
Sensitivity (pD2: -logEC50), Maximum Response (Rmax), and Area Under the Curve to ACh in Mesenteric Arteries from
Ovariectomized and E2 Replaced SD Control and Prediabetic Rats
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Figure 2.6 Relaxation responses to cumulative concentrations of sodium nitroprusside (SNP) (109
to 10-5 M) in intact mesenteric arterial rings pre-contracted with phenylephrine (PE, 2 μM) from
ovariectomized and E2 replaced SD control and prediabetic rats. Data are expressed as mean ±
SEM. n= 4-5 per group. Parenthesis indicates significant difference (p<0.05) between groups
analyzed using 2-way ANOVA followed by Tukey’s post hoc test.
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Table 2.4
Sensitivity (pD2: -logEC50), and Maximum Response (Rmax) to Sodium Nitroprusside (SNP) in
Mesenteric Arterial Rings from Ovariectomized and E2 Replaced SD Control and Prediabetic Rats
SNP

n

pD2

Rmax (%)

OVX

5

6.59±0.2

86.6±3.0

OVX+E2

4

8.17±0.2#

101.7±0.6

PD OVX

4

3.67±0.2*#

19.12±4.3*#

PD OVX+E2

4

5.49±0.6*$

57.68±7.5*#$

Data are expressed as mean ± SEM; n=4-5 rats per group. #p<0.05 (vs. OVX), *p<0.05 (vs.
OVX+E2), $p<0.05 (vs. PD OVX), analyzed using one-way ANOVA followed by Tukey’s post
hoc test.
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Figure 2.7 Concentration-response curves to phenylephrine (PE, 10-8 to 10-5 M) in intact
mesenteric arterial (MA) rings of ovariectomized and E2 replaced SD control and prediabetic rats.
Data are expressed as mean ± SEM. n=4-5 per group. *p<0.05 between two groups analyzed
using two-way ANOVA followed by Tukey’s post hoc test.
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Table 2.5
Sensitivity (pD2: -logEC50), and Maximum Tension (Tensionmax) to Phenylephrine (PE) in Rat
Mesenteric Arterial Rings from Ovariectomized and E2 Replaced SD Control and Prediabetic
Rats
PE

n

pD2

Tensionmax (mN)

OVX

5

6.02±0.1

9.91±1.8

OVX+E2

5

5.93±0.2

9.75±0.5

PD OVX

5

5.92±0.1

16.75±1.3*#

PD OVX+E2

4

5.96±0.1

15.91±0.4*#

Data are expressed as mean ± SEM; n=4-5 rats per group. #p<0.05 (vs. OVX), *p<0.05 (vs.
OVX+E2), analyzed using one-way ANOVA followed by Tukey’s post hoc test.
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Figure 2.8 Western blot analysis of (A) eNOS (B) ER-β expression in mesenteric artery of
ovariectomized and E2 replaced SD control and prediabetic rats. Protein level were quantified by
densitometry and normalized to corresponding GAPDH. Values are represented as mean ± SEM.
Each bar represents the values obtained from n=3-4 animals per group. Representative bands of
target and housekeeping protein (GAPDH) were shown from the same membranes. Capped lines
indicate significant differences between two groups (*p<0.05, **p<0.01) as analyzed by one-way
ANOVA followed by Tukey’s post hoc test.
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Figure 2.9 Western blot analysis of ER-α expression in mesenteric artery of ovariectomized and
E2 replaced SD control and prediabetic rats. Protein level were quantified by densitometry and
normalized to corresponding GAPDH. Values are represented as mean ± SEM. Each bar
represents the values obtained from n=3-4 animals per group. Representative bands of target and
housekeeping protein (GAPDH) were shown from the same membranes. Data was analyzed by
one-way ANOVA followed by Tukey’s post hoc test.
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Figure 2.10 Western blot analysis of NOX-1 expression in mesenteric artery of ovariectomized
and E2 replaced SD control and prediabetic rats. Protein level were quantified by densitometry
and normalized to corresponding GAPDH. Values are represented as mean ± SEM. Each bar
represents the values obtained from n=3-4 animals per group. Representative bands of target and
housekeeping protein (GAPDH) were shown from the same membranes. Capped lines indicate
significant differences between two groups (**p<0.01, ****p<0.0001) as analyzed by one-way
ANOVA followed by Tukey’s post hoc test.
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2.4 Discussion
Here, we set out to study the influence of E2 replacement on MA function in OVX female
UCD-T2DM rats at the prediabetic stage. We observed that ACh relaxation responses were
impaired in MA of OVX prediabetic UCD-T2DM rats, and E2 treatment improved MA
relaxation in this group. Additionally, we showed that the improved vasorelaxation of MA in E2
treated PD OVX rats could be in part due to enhanced contribution of NO to ACh responses.
Lack of estrogen in postmenopausal women results from loss of ovarian activity.
Postmenopausal women are at higher risk for metabolic and cardiovascular abnormalities such as
obesity and T2D (Chen et al., 2019; Mauvais-Jarvis et al., 2017; Sternfeld et al., 2005). Changes
in lipid metabolism, and body fat composition and distribution with estrogen deficiency are
thought to be the main factors contributing to an elevated risk of metabolic syndrome and CVD
in postmenopausal women compared to premenopausal individuals (Lovejoy et al., 2008;
Mauvais-Jarvis et al., 2017). In the present study, we used OVX female rats to evaluate the
effects of ovarian hormone deficiency and E2 replacement on the metabolic and vascular
function, as well as the expression of specific markers involved in insulin signaling in healthy
and prediabetic UCD-T2DM rats.
Both OVX and PD OVX groups exhibited significantly higher body weight compared to
their respective E2-treated groups. In addition, when the abdominal fat percentage to total body
weight was compared, the PD OVX group showed significantly higher abdominal fat compared
to all other experimental groups. E2 treatment, however, significantly reduced abdominal obesity
in both OVX and PD OVX rats, indicating a potential role of estrogen in reducing abdominal
obesity. It was reported that an increased fat and body mass occur as a result of ovariectomy
(Latour et al., 2001; Laudenslager et al., 1980; Rachoń et al., 2007; Richard et al., 1987).
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Previous studies have shown that E2 replacement in OVX rodents decreases abdominal
fat accumulation, improves serum lipid profiles (Shinoda et al., 2002; Wu et al., 2004), and
restores insulin action on muscle glucose transport (Kumagai et al., 1993; Puah & Bailey, 1985).
Along similar lines, Ritland et al. reported in postmenopausal women, central obesity could be
related to a decrease in adiponectin levels in serum (Ritland et al., 2008). However, in another
report, Babaei et al. showed that ovarian hormone withdrawal leads to higher body weight and
visceral adipose tissue in rats but surprisingly does not change adiponectin levels (Babaei et al.,
2010). In Babaei’s report, although a substantial decrease in body weight was achieved by
estrogen replacement in OVX animals, the beneficial metabolic effects of weight loss seem to be
related to a tendency in improving insulin sensitivity without elevating adiponectin production.
The underlying molecular and cellular mechanisms of the metabolic actions of estrogen
are poorly understood. Much of our current view of the actions of estrogen on adiposity and
metabolism derives from the ovariectomized rodent model of menopause. In the present study,
we did not measure adiponectin level; however, when glucose and HbA1c levels were compared
among the experimental groups, the PD OVX group showed significantly higher glucose and
HBA1c levels compared to both E2 treated groups. Although the OVX group showed a slight
increase in glucose and HbA1C levels compared to those in the OVX + E2 group, the difference
didn’t reach to a significant level.
The correlation between menopause and dysglycemia remains controversial. Kim et al.
reported no association of natural menopause with T2D (Kim et al., 2011). However, Heianza et
al. reported postmenopausal status is associated with dysglycemia independent of age (Heianza
et al., 2013). Ovariectomy in rats has been reported to cause decreased (Kumagai et al., 1993;
Rincon et al., 1996) or unchanged glucose tolerance tests (Latour et al., 2001). Decreased
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insulin-stimulated glucose transport in SKM of OVX rodents has also been reported (Kumagai et
al., 1993; Puah & Bailey, 1985).
Chronically elevated insulin without hypoglycemia is common in obesity and metabolic
disorders, and it is referred to as hyperinsulinemia. Prior to overt metabolic disorder, abnormally
elevated lipid level and hyperinsulinemia are reported (Erion & Corkey, 2017). In subjects with
obesity but without diabetes, hyperinsulinemia and insulin hypersecretion are more prevalent
than insulin resistance (Ferrannini et al., 1997; Thomas et al., 2019; Weyer et al., 2000) and
hence may precede and contribute to insulin resistance. Furthermore, it has been shown that
hyperinsulinemia is self-perpetuating and is more likely to be a primary defect rather than a
compensation for insulin resistance in the general population (Mari et al., 2011; Tricò et al.,
2018). Here, we observed a significant increase in triglyceride and insulin levels in the PD OVX
group. Although the intact prediabetic groups were not included in the current study, our recent
report on metabolic parameters in intact prediabetic male and female rats showed comparable
metabolic values to those observed in PD OVX and PD OVX+E2, respectively (Shaligram et al.,
2020). Overall, these data would appear to support E2 protection against weight gain, central
adiposity, dyslipidemia, and hyperglycemia.
Insulin resistance is an important characteristic in the pathogenesis of T2D. SKM is the
primary organ which under normoglycemic conditions is responsible for approximately 80% of
insulin-mediated glucose uptake (DeFronzo & Tripathy, 2009; Klip & Pâquet, 1990). Therefore,
SKM has been shown to play an important role in determining glycemic status. Consistent with
the increases in circulating glucose and insulin levels in PD OVX, the expression of IRS1, a
substrate of insulin receptor tyrosine kinase with a central role in the insulin signaling pathway
and glucose uptake in SKM (Kovacs et al., 2003), was significantly low in SKM of this group.
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Remarkably, we also observed a lower level of GLUT-4 expression in SKM of OVX groups
compared to E2 treated groups, regardless of disease status. Along similar lines, Gorres et al.
recently reported estrogen treatment improved insulin signaling and enhanced SKM glucose
uptake in OVX SD rats (Gorres et al., 2011).
An alternative pathway for GLUT-4 translocation to the membrane and increasing
glucose transport, independent of insulin, is by phosphorylation of AMP-activated protein kinase
(AMPK) (Gorres et al., 2011). AMPK is an energy-sensing enzyme that is activated when
cellular energy levels are low, and it signals to stimulate glucose uptake in SKM, among other
insulin-sensitizing effects. There is substantial evidence suggesting that AMPK is dysregulated
in animals and humans with T2D and that AMPK activation (physiological or pharmacological
or hormonal) could improve insulin sensitivity (Coughlan et al., 2014). E2 treatment is shown to
increase AMPK activation in C2C12 myotubes (D’Eon et al., 2008). However, in the current
study, E2 treatment only increased phosphorylated AMPK-α (p-AMPK-α) in the PD OVX group
but not in the OVX. Although we did not attempt to elucidate the underlying mechanisms
responsible for the enhancement of p-AMPK-α by E2 treatment in the SKM of the PD OVX
group, D’Eon et al. reported that E2 promotes the partitioning of free fatty acids toward
oxidation and away from triglyceride storage in SKM by up-regulating the expression of
peroxisome proliferation activator receptor-δ (PPAR-δ) and its downstream targets and also by
directly and rapidly activating AMP-activated protein kinase (D’Eon et al., 2005). Thus, the
elevated SKM expression of p-AMPK-α observed in E2-treated PD OVX may suggest that at the
elevated glycemic condition, female sex hormone, in particular E2, may have a beneficial effect
in lowering glucose levels, in part, by AMPK activation.
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In the current study, we observed a comparable trend between increased SKM GLUT-4
and p-AMPK expression and improved vascular function, as ACh relaxation was significantly
enhanced in E2 treated OVX during the prediabetic stage.
Endothelial dysfunction is considered the initiating factor for vascular complications in
diabetes (Bakker et al., 2009; Eringa et al., 2013; Takenouchi et al., 2009). A commonly used
technique to investigate endothelial dysfunction is by investigating EDV. Here we specifically
demonstrated that E2 replacement did not cause any changes in EDV in the ovariectomized rats.
The ACh Emax were 99.7± 0.2% and 100.1 ± 0.1% in arteries of OVX and OVX + E2,
respectively. It is also important to note that there were no statistical differences in the ACh pD2
values between OVX and OVX+E2, and the values were in line with our recent report in
normoglycemic male and female arteries (Shaligram et al., 2020). Therefore, our data suggest
that ovariectomy for 7 weeks did not cause any EDV dysfunction in healthy controls. It has been
reported that endothelial dysfunction gradually increases following ovariectomy, and the
maximal effects of ovariectomy on vasculature could be overserved at 12 weeks in
normoglycemic rats (Moien-Afshari et al., 2003). In the current study, the EDV was however
significantly impaired in PD OVX groups. Accordingly, Vehkavaara et al. reported that a higher
glucose level, but not as high as the diabetic state, could still lead to vascular dysfunction
(Vehkavaara et al., 1999). We specifically showed that in absence of E2, relaxation responses in
MA of OVX prediabetic animals were significantly impaired. However, an intriguing
observation of this study was that E2 replacement restored the relaxation responses in the PD
OVX group (Figure 2.4, Table 2.2). These observations are in line with our recent report
showing that vascular relaxation to ACh was impaired to a greater extent in MA from males in
the prediabetic stage than in their female counterparts (Shaligram et al., 2020).
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Sex difference in vascular function is well studied (Miller, 2010; Shaligram et al., 2020).
However, T2D abolishes the sex based protective effect against cardiovascular diseases in
premenopausal women (Steinberg et al., 2000). Here, our data reinforces our hypothesis that
female sex hormones may, in fact protect the effect of prediabetes on endothelial function. To
the best of our knowledge, this study is the first to characterize the role of E2 on vascular
function as early as the prediabetic stage.
It has been shown that both NO-dependent and NO-independent mechanisms are
involved in rat mesenteric arterial relaxation (Zygmunt et al., 1995). However, the specific role
of E2 on NO and NO-independent pathways in the prediabetic state is not clear. In the present
study, we showed that the effects of Indo and L-NAME on mesenteric artery vasorelaxation in
ovariectomized rats were dependent on disease as well as the presence of E2. The inhibition of
COX metabolites by Indo slightly but not significantly reduced sensitivity to ACh-mediated
mesenteric relaxation in all four experimental groups, suggesting that metabolites in the COX
pathway play only a minor role in EDV of mesenteric arteries. Consistent with this
interpretation are data demonstrating that COX metabolites have a less important role in the
relaxation of smaller arteries, such as mesenteric arteries (Shimokawa et al., 1996). When LNAME is administrated after Indo, the further reduction in EDV is generally considered to
represent the role of NO. Any remaining EDV to ACh after incubation with Indo and L-NAME
is referred to as the L-NAME/Indo-insensitive component, or EDHF-type relaxation (Feletou &
Vanhoutte, 1988; Komori et al., 1988). This remaining EDV can be subsequently blocked by
inhibiting small and intermediate conductance calcium-activated potassium channels (SKCa and
IKCa) (Doughty et al., 1999).
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In all four experimental groups, the addition of L-NAME led to a further reduction of
EDV (Figure 2.5A-D). However, the added effect of L-NAME in blunting ACh-mediated
vasodilation was much more prominent and completely blocked the remaining relaxation
responses to ACh in prediabetic arteries when compared with their respective control (Figure
2.5C-D). Overall, these data suggest that in OVX control groups, regardless of E2 replacement,
both NO and EDHF contributed to the MA relaxation responses (Figure 2.5A-B, Table 2.3).
This observation is also in line with published reports by us and others who investigated ACh
relaxation in mesenteric arteries of intact male and female rats (McCulloch & Randall, 1998;
Shaligram et al., 2020; Zhang et al., 2012). Here, we show that in prediabetic animals, NO is
the only contributor to mesenteric relaxation and EDHF type relaxation is absent, regardless of
presence or absence of E2. The alteration of EDHF contribution in the small arteries of diabetic
animals has been shown by other investigators and us (Fukao et al., 1997; Oniki et al., 2006; Shi
et al., 2006). Therefore, the impairment of relaxation responses to ACh observed in the OVX
prediabetic rats may, in part, be due to loss of EDHF-mediated relaxation, which is one of the
major vasodilatory mediators in arteries in these groups. However, an intriguing observation of
this study was that E2 replacement significantly increased the NO contribution to ACh
vasorelaxation in prediabetic group (PD OVX+E2) when compared to their respective controls
(PD OVX or OVX+E2). Therefore, it is possible that observed enhanced relaxation in the E2
treated prediabetic models could be mediated by the elevated contribution of NO in vascular
relaxation in this group.
Several investigators, including our group (Thor, Uchizono, et al., 2010; Lahm et al.,
2008; Montgomery et al., 2003), have previously shown that the vascular effects of E2 are
mediated via ER-α and ER-β subtypes, and in part by augmenting the function of eNOS (Lantin-
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Hermoso et al., 1997; Weiner et al., 1994). Here, we didn’t directly measure eNOS activity, but
our data show that the expression of ER-β (but not ER-α) was enhanced while the expression of
eNOS was not changed in MA from E2 treated OVX prediabetic rats compared to placebotreated prediabetic rats. Additional studies will be needed to document the relative importance
of NO to elevated relaxation responses in E2 treated prediabetic rats.
In addition to a possible role for altered contributions of endothelial NO, other
mechanisms that could explain the improved vascular function of prediabetes in the presence of
E2 may include factors such as enhanced sensitivity of MA to NO or decreased vasoconstrictor
response to agents such as PE. Here, we observed that MA relaxation to SNP, an indicator of
arterial sensitivity to NO, was clearly impaired in the prediabetic models. Therefore, the
impaired responses to ACh in prediabetic models may in part occur at NO interaction with MA.
This finding is in agreement with our recent report on impairment of SNP-induced relaxation in
both prediabetic males and females (Shaligram et al., 2020). However, interestingly, E2
replacement significantly increased the SNP-induced relaxation in both healthy and prediabetic
groups when compared to their respective controls (OVX and PD OVX), suggesting that
enhanced sensitivity of MA to NO in E2 treated prediabetic arteries may in part be responsible
for the enhanced vasorelaxation in this group.
We also examined the vasoconstrictor response to PE, an α-adrenoceptor agonist. We
showed no changes in the sensitivity to PE in rat mesenteric arteries of prediabetic groups
compared with non-prediabetic groups, irrespective of the presence or absence of E2. However,
maximal contractile responses were significantly higher in prediabetic groups compared with
non-prediabetics, regardless of E2 treatment.
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Theoretically, the enhanced responses to PE observed in prediabetic models (Figure 2.7,
Table 2.5) may partially result from a decreased release of relaxing factors (NO or EDHF), a
reduced sensitivity of MA to NO, or an enhanced release of contracting factors.
Here, we did not measure endothelium-derived contractile factors. Still, consistent with
our working hypothesis are data demonstrating that expression levels of NOX-1 catalytic subunit
of NADPH oxidases, the major source of superoxide in the vessel wall, was significantly
elevated in MA taken from prediabetic rats compared with healthy rats. Although the functional
consequence of elevated NOX-1 expression in MA of prediabetic rats was not investigated, these
data were in line with elevated PE responses in these groups. In diabetes, superoxide production
has been shown to play an important role in activating endothelium-derived contracting factorsmediated responses (Shi et al., 2007; Shi & Vanhoutte, 2008; Vanhoutte & Tang, 2008; Zhang et
al., 2012). Interestingly, in prediabetic groups, E2 treatment resulted in a decrease in the NOX-1
level, although the difference was not statistically significant compared to the absence of E2.
In summary, we have shown that mesenteric endothelial function in ovariectomized
prediabetic rats was severely impaired. Furthermore, this study suggests that the predisposition
of ovariectomized rat mesenteric arteries to vascular injury at the prediabetic state may be due to
a shift away from a putative EDHF, initially the major vasodilatory factor, toward a reliance on
NO. However, our data showed that the E2 replacement preserved vasorelaxation in prediabetic
rats. Thus, the basis for the protective effects of E2 on the vascular relaxation may be partly
attributed to the enhancement of NO sensitivity and its contribution to vascular relaxation as well
as improved insulin signaling and elevated SKM glucose uptake in this group. Overall, the shift
from EDHF-type relaxation towards a greater reliance on NO in estrogen replaced prediabetic
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group could be a possible compensatory mechanism to protect female arteries from early
vascular dysfunction.
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CHAPTER 3: STUDY II: EFFECTS OF MODERATE-INTENSITY AEROBIC
EXERCISE (MIE) ON MESENTERIC ARTERIAL FUNCTION AND WALL
STRUCTURE IN MALE UC DAVIS TYPE 2 DIABETES MELLITUS (UCD-T2DM)
RATS

3.1 Introduction
The prevalence of type-2 diabetes (T2D) is rising globally due to obesity and physical
inactivity overlaid on a genetic predisposition, among other factors. It is generally believed that
T2D and cardiovascular diseases (CVD) can be prevented and managed with healthy food
choices and routine physical activity. Exercise prevents CVD by reducing cardiometabolic risk
factors (i.e., insulin resistance, glucose intolerance, circulating lipid concentration) and
improving cardiovascular function and adaptation (Padilla et al., 2011; Pinckard et al., 2019).
Although regular aerobic exercise is a proven method for intervening endothelial dysfunction,
insulin resistance, and cardiovascular risk in T2D (Okada et al., 2010), there is still debate about
the intensity and type of exercise required to prevent CVD in diabetes.
Increased CVD risk in diabetes is associated with vascular structural, mechanical, and
functional alteration. These alterations include increased wall to lumen ratio and stiffness,
impaired endothelium dependent vasodilation (EDV), and enhanced responses to
vasoconstricting agents (Bagi et al., 2005; De Vriese et al., 2000; Schofield et al., 2002; SouzaSmith et al., 2011). Endothelial dysfunction and impaired EDV, which precede overt CVD in
diabetes, can occur through a myriad of pathways. The fundamental mechanisms include insulin
resistance and impaired endothelial nitric oxide synthase (eNOS) activation through IRS1/PI3K/Akt pathway, increased oxidative stress, and reduced nitric oxide (NO) bioavailability,
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and pro-inflammatory activation of the endothelium (Tabit et al., 2010). Increased oxidative
stress is linked with reduced bioavailability of NO, increased vascular inflammation, and adverse
vascular remodeling (Touyz et al., 2002). Regular physical activity was correlated with reduced
oxidative stress and inflammation in pathologic conditions such as hypertension (Briones &
Touyz, 2009). Increased shear stress due to repeated bouts of aerobic exercise could also
increase NO and endothelium-derived hyperpolarization factor (EDHF) production by
stimulating endothelial cells (Traub & Berk, 1998; Takamura et al., 1999). Despite reported
anti-inflammatory, antioxidant, and improved generation of endothelium-derived relaxing factors
(EDRF) by exercise training, too little is known about the mechanism by which exercise
mediates vascular benefits in diabetes, possibly due to the use of different intensity, type, and
duration in rodent models and human.
EDRFs, mainly NO and prostacyclin (PGI2), beside controlling vascular tone, also
control other vital aspects that may determine vascular health and atherosclerosis. NO, and PGI2
are well known for their inhibitory effect on platelet aggregation, leukocyte adhesion and
migration, and vascular smooth muscle cell (VSMC) proliferation and inflammation (Traub &
Berk, 1998). VSMC proliferation and/or hypertrophy, also described as an increase in intima
medial thickness (IMT), is a marker of atherosclerosis (de Groot et al., 2004; McCloskey et al.,
2014). Sedentary lifestyle reduces the shear stress on the arterial wall, and subsequently reduces
the production of NO and PGI2, and promotes thickening of intima-media (Gnasso et al., 1996).
Besides IMT, increased collagen deposition and reduced elastin content have been reported in
aged rat arteries which increase stiffness (Briones et al., 2007). Increasing evidence suggests,
besides shear stress induced increase in production of EDRFs, the beneficial effect of exercise
against CVD is obtained partly due to its direct impact on arterial wall properties such as elastin
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and collagen content, wall thickness, wall to lumen ratio (Matsuda et al., 1993; Thijssen et al.,
2012; Xiong et al., 2021). Despite these reports, the impact of exercise on diabetic arterial wall
remodeling is not well understood.
The current study was designed to investigate the impact of moderate-intensity aerobic
exercise (MIE) on vascular reactivity and structural remodeling of vessels in male (and female in
future studies) diabetic UCD-T2DM rats. We hypothesize that MIE enhances mesenteric arterial
(MA) relaxation by alteration of the relative contributions of EDRF and the expression of genes
or activity of gene products associated with EDV. Furthermore, exercise training enhances EDV
by altering the MA wall structure (collagen and elastin content, wall thickness) and myogenic
tone in UCD-T2DM male rats. To test the hypotheses mentioned above, we investigated the
effects of eight weeks of MIE on the 1) ACh-induced EDV and vascular responses to contractile
agents, 2) contribution of EDRF in vasorelaxation, 3) expression of proteins associated with NO, cyclooxygenase (COX)-, and EDHF-mediated vasorelaxation and vasoconstriction, and 4)
pressure-induced change of myogenic tone, wall thickness, and elastin content in arteries (such
as MA and aorta) isolated from male UCD-T2DM rats.
This study demonstrates that eight weeks of MIE improved vasorelaxation in MA from
male UCD-T2DM rats. Here we provide the first report of the specific impact of MIE on the
modulation of EDRF, myogenic tone, contractile response, and wall properties which may have
improved EDV in the UCD-T2DM model.
3.2 Materials and Methods
3.2.1 Chemicals
All chemicals were purchased from either Fisher Scientific (Waltham, MA) or Sigma
Aldrich (St. Louis, MO, USA) and dissolved in water unless otherwise stated.
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3.2.2 Experimental Animals
For this study, we selected 19-20 weeks old male UCD-T2DM rats that developed overt
diabetes. The mean diabetic age was (32±2) days at the time of exercise initiation. Age-matched
Sprague Dawley (SD) rats were ordered from the Simonsen laboratory. Both diabetic and SD
rats were randomly divided into either exercise-trained or sedentary groups. In total, four
experimental groups were selected: 1) Control Sedentary (CS), 2) Control Exercise-trained (CE),
3) Diabetic Sedentary (DS), and 4) Diabetic Exercise-trained (DE).
The exercise-trained groups were acclimatized with the treadmill for one week (5 days).
The acclimation protocol is elaborated in table 3.1 and adopted from (Teixeira-Coelho et al.,
2017). After acclimation, the rats underwent MIE over the next eight weeks (1 hour/day,
5days/week). The exercise training was divided into two sessions/day with a 5 mins break to
ensure the obese diabetic animal could complete the 1-hour session without exhaustion. The
details of the exercise training protocol are elaborated in table 3.2.
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Table 3.1
Five-days Acclimation Protocol for Running on a Treadmill
1st day

2nd day

3rd ,4th ,5th day

5 min (rest)

5 min (rest)

5 min (rest)

1 min (10 m/min)

1 min (12 m/min)

5 min (15 m/min)

1 min (12 m/min)

5 min (15 m/min)

5 min (15 m/min)

Table 3.2
Moderate-intensity Treadmill Running Protocol for SD Control and Diabetic Rats. The Protocol
Was Followed for 5days/week for Eight Weeks
1st session

2nd Session
5 mins

5 mins warm up

25 mins MIE

25 mins MIE

5 mins cool down

15m/min

10m/min

break
Speed:

10m/min

15m/min
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MIE is defined as the exercise intensity at which the oxygen consumption reaches 5065% of the maximum oxygen consumption (VO2max). Previous studies in rodents have used
treadmill speed ranging from 12-18m/min with various inclinations for MIE (Chung & Diffee,
2012; Howarth et al., 2008; Yang et al., 2020). We selected the speed of 15m/min with 0%
inclination on the treadmill for our protocol. The sedentary group is placed on the stationary
treadmill three times a week to provide a matched environment without MIE.
During the study period, all the animals at the University of the Pacific vivarium were
kept in a humidity and temperature-controlled room with a 12h light/dark cycle and ad libitum
access to water and standard rodent chow (Mazuri rodent chow). The animals were euthanized
using carbon dioxide after eight weeks of MIE. The euthanasia processes were completed by
following AVMA Guidelines for the Euthanasia of Animals: 2013 edition and the NIH
Guidelines for the Care and Use of Laboratory Animals: Eighth Edition. In addition, all animal
protocols were approved by the Institutional Animal Care and Use Committee of the University
of the Pacific. After the rats were sacrificed, the isolated MA function and wall characteristics
were investigated using the wire and pressure myography technique.
3.2.3 Measurement of MA Tension by Wire Myography
Please see chapter 2, section 2.2.4, for a detailed experimental protocol.
3.2.3.1 Relaxation Responses to Sodium Nitroprusside (SNP)
Relaxation responses to SNP, a NO donor, were slightly modified from the first study to
measure the smooth muscle sensitivity. MA segment was incubated for 20 mins with a
combination of indomethacin (Indo, 10µM), Nω-nitro-L-arginine methyl ester (L-NAME,
200µM), Apamin (1 µM) and 1-[(2-Chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34,
1µM) to prevent the contribution of EDRF from endothelial cells on the relaxation of smooth
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muscle. Concentration response curves (CRC) to increasing dosage of SNP (10 to 10 M) were
obtained in MA precontracted with phenylephrine (PE, 2µM).
3.2.4 Measurement of MA Myogenic Tone and Wall Thickness by Pressure Myograph
Pressure myograph is a strong tool to investigate myogenic tone, wall thickness, wall to
lumen ratio, and change of inner diameter of artery at different pressures. The myogenic tone is
a contractile response which is generated when the blood vessel is stretched radially due to
increased intravascular pressure. Similar to study-I, the 3rd order MA was isolated by clearing
from fat and other connective tissues and mounted on the glass cannula of a Danish Myo
Technology (DMT) pressure myograph (DMT 114p). Both ends of the artery were secured on
the cannulas by a thin nylon suture so that the artery and the cannulas together make a close
system. The MA was then checked for any leak by pushing a small amount of the Krebs solution
into the system. When the arteries maintained the bulbous formation, the system was considered
a close system. Care was taken not to introduce any bubble in the system. The MA was then
pressurized to 120mm Hg and checked for any bends. Any bend observed in the MA segment
was corrected by stretching the artery using the horizontal movement screw. The MA segment
was allowed to rest at 60mmHg for 30 mins, and then the viability of the arteries was determined
by assessing ACh (10µM) mediated relaxation in PE (2µM) precontracted arteries. The artery
segment was washed and allowed to rest for 20 mins before moving onto pressurized
experiments.
MA inner and outer diameter, wall thickness, and myogenic tone were assessed over
increasing intraluminal pressures in steps between 20-120 mmHg. The MA was allowed to
develop a spontaneous tone by reaching a stable diameter (Active Diameter, Da) at each pressure
step, which was typically achieved over 5 min intervals. The pressure-response was repeated in
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Ca free physiological salt solution (PSS) to determine the corresponding passive diameters
(Dp). The myogenic tone is expressed as a percent of passive diameter (Dp) and calculated as (Dp
– Da)/ Dp x100. Myoview software, in combination with an inverted microscope (Zeiss Axio
Vert.A1) connected with a camera, was used to record data for vascular wall characteristics (wall
thickness, inner and outer diameter) at different pressures.
3.2.5 Western Blot Analysis
Please see chapter 2, section 2.2.5, for a detailed procedure. Additionally, the primary
antibody for COX-1 was obtained from cell signaling technology (Danvers, MA), and an
antibody against COX-2 was obtained from Abcam (Cambridge, MA). All primary antibodies
were diluted to 1:1000 unless otherwise stated. The dilutions of secondary antibody were either
1:10000 or 1:15000.
3.2.6 Histological Studies of the Aortic Wall
Formalin-fixed paraffin-embedded aortic tissues were used for immunohistochemical
analysis. Briefly, the aortic (2mm) segment was fixed in 10% formalin and dehydrated using
increasing concentrations of ethanol. Aortic sections were then immersed in xylene and finally
embedded in paraffin to make a block. The paraffin-embedded tissues are then sectioned at a
thickness of 4-5µm using a microtome (MICROM HM 325, Thermo Fisher Scientific, Waltham,
MA) and put on the warm water bath to stretch. Finally, the sections were fixed on a glass slide
for further analysis.
3.2.6.1 Hematoxylin and Eosin Staining of the Aorta
To investigate the general histology of the aortic wall, aortic sections were stained by
hematoxylin and eosin (H&E). Briefly, aortic sections on the glass slides were deparaffinized
and immersed into water for rehydration. The hydrated sections were stained using hematoxylin
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and eosin stain kit (Vector Lab, Burlingame, CA) following the manufacturer’s protocol. The
pictures of stained aortic sections were taken by a camera attached with a light microscope
(Nikon Eclipse E200). The intima medial thickness of the aorta was measured by a line tool
software provided by Nikon (NIS Element D). 4-5 pictures were taken from different areas of
the same aorta, and measurements were taken from at least three different areas of each picture.
All the readings were averaged, and the aortic mean medial thickness was determined for that
animal.
3.2.6.2 Verhoeff Van Gieson Staining of the Aorta:
Aortic sections were also stained to investigate elastin content using the Verhoeff Van
Gieson stain kit (StatLab, McKinney, TX) and following the manufacturer’s protocol. Like
H&E staining, 4-5 pictures were taken per aorta, and the area of elastin and the total area were
analyzed using ImageJ software (NIH). Elastin content was expressed as a percentage of the
total area.
3.3 Results
3.3.1 Effects of MIE on Metabolic Parameters
MIE significantly reduced the body weight in the diabetic group; however, it did not
reach to the level of control groups. The body weight was 383.3±4.2 g in CS and 366.7±5.1 g in
CE, and 559.3±30.4 g in DS and 469.3±6.2 g in DE (Figure 3.1A, Table 3.3). The normalized
(to body weight) intra-abdominal adipose tissue level (located around mesentery and omental)
was significantly higher in DS groups compared to the exercise-trained control and diabetic
group (Figure 3.1B). Similarly, when circulating triglyceride levels were compared, the DS
group showed significantly higher triglyceride level (3.52±0.3 mmol/L) compared to CS, CE,
and DE (1.35±0.2, 1.36±0.1, and 1.54±0.2 mmol/L, respectively). However, MIE had no
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significant effect on blood glucose, HbA1c, and plasma insulin level regardless of disease status.
Blood glucose and HbA1c levels were higher, and plasma insulin levels were lower in diabetic
groups than in the control group (Figure 3.1D-F).
3.3.2 Effects of MIE on Relaxation Responses to ACh
Both sensitivity (pD2) and maximal response (Rmax) to ACh were significantly reduced in
MA from DS rats compared with those in CS. Interestingly, exercise improved the ACh
response only in the MA of the diabetic group (DE); the Rmax to ACh in MA rings in the DE
group (90.74±2.4%) was markedly enhanced compared to DS (59.85±2.2%) (Figure 3.2 Table
3.4). Similarly, MA from DE animals showed improved sensitivity [pD2(-logEC50)] to ACh
(6.72±0.1) compared to the respective sedentary group (5.80±0.2).
3.3.3 Effects of MIE on the Relative Contribution of EDRF to MA Relaxation
The relative contributions of COX metabolites, NO, and EDHF to vasorelaxation induced
by ACh were estimated by sequentially inhibiting COX, NOS, and a combination of small and
intermediate conductance calcium-activated potassium channel (SKCa and IKCa) inhibitors.
Inhibition of COX by Indo enhanced ACh-induced Rmax from 59.85±2.2% to 98.61±0.4% in DS
arteries, suggesting the elevation of contractile COX metabolites in the DS group (Figure 3.3 C,
Table 3.5). The addition of L-NAME resulted in a reduction in ACh-induced vasorelaxation of
arteries from both control and diabetic sedentary rats. However, the effect was more prominent
(and almost completely blocked ACh relaxation) in the DS group (DS vs. CS, Figure 3.3 A, C).
The difference in area under the curve (ΔAUC) between ACh CRCs before and after an inhibitor
was calculated as described in our previous study (Sangüesa et al., 2017). Particularly, an
intriguing observation was that MIE prevented the loss of EDHF-mediated relaxation in male
UCD-T2DM rats (DE vs. DS, Figure 3.3 C-D). The Rmax of ACh-induced vasorelaxation after
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Indo+L-NAME was 10.27±3.7% and 38.58±13.9% in DS and DE groups, respectively.
Additionally, ΔAUC of Indo and L-NAME resistant relaxation was significantly lower in DS
(6.24±1.83) compared to DE (48.38±9.1) (Figure 3.3C-D, gray shaded area; Table 3.5, column
of Indo+L-NAME+Apamin+TRAM-34). Furthermore, unlike in the DS group, inhibition of
COX with Indo did not affect ACh responses in MA of the DE group (DE vs. DS, Figure 3.3CD).
3.3.4 Effects of MIE on the SNP-induced Relaxation
To investigate whether impaired smooth muscle sensitivity to NO led to reduced MA
relaxation of DS rats, we examined the relaxation responses to SNP (NO donor). There was no
significant difference observed between the CRCs to SNP regardless of MIE and/or disease
status in any of the experimental groups (Figure 3.4, Table 3.6).
3.3.5 Effects of MIE on COX-1 and COX-2 Expression
COX metabolites are major regulators of vascular tone. Matsumoto et al. suggested that
in T2D OLETF rats, impaired EDV of MA could be due to the overexpression of COX-1 and
COX-2 as well as increased production of vasoconstrictive prostanoids (Matsumoto et al., 2007).
In the current study, we observed an increase in MA relaxation in DS arteries by ACh in
presence of Indo, suggesting an elevated contractile function of COXs in DS arteries. Hence, we
have investigated both subtypes of COX (COX-1 and COX-2) expression in MA. Arteries taken
from the DS group exhibited a greater level of both COX isoforms than those in exercise-trained
groups (CE, DE) (Figure 3.5).
3.3.6 Effects of MIE on eNOS Expression
We observed a relative contribution of NO-mediated relaxation in diabetic groups
compared to control groups. Zhang et al. reported an increase in eNOS gene expression in MA
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of type-1 diabetic female rats, which was possibly correlated with the elevated NO contribution
to EDV (Zhang et al., 2012). To investigate the origin of elevated NO-mediated relaxation, we
determined the eNOS protein expression in the MA of experimental groups. Both DS and DE
showed significantly higher eNOS expression than the CS and CE groups, approximately 4 and 3
folds, respectively (Figure 3.6).
3.3.7 Effects of MIE on IKCa and SKCa Expression
We observed a diminished EDHF-type relaxation in DS arteries, and MIE improved
EDHF-type relaxation in the diabetic group. To determine whether EDHF-type relaxation was
associated with the alteration of calcium-activated potassium channels, we investigated the
expression of small and intermediate conductance calcium-activated potassium channels (SKCa
and IKCa) in MA. There were no significant changes in the expression of IKCa in MA of any
groups (Figure 3.7A). However, SKCa expression in DS was significantly reduced compared to
CS and CE. When only diabetic groups were compared, SKCa level was significantly higher
(0.3-fold) in DE than in the DS group (Figure 3.7B, top right section, DS vs. DE bar graph,
analyzed by t-test).
3.3.8 Effects of MIE on the PE-induced Contraction of MA
A dysfunctional endothelium also becomes a source of other substances and mediators
that are detrimental to the arterial wall, such as thromboxane A2 (TXA2) and prostaglandin H2
(PGH2)(Taddei et al., 2005). These factors have pro-atherosclerotic features and also cause
vasoconstriction via activation of thromboxane prostanoids receptors (TP) on vascular smooth
muscle (VSM). We, therefore, compared the CRCs to a contractile agent PE (10-8 to 10-5 M) in
MA from the experimental groups. The MA from the DS group exhibited a higher maximal
contractile response to PE than all other experimental groups (Figure 3.8, Table 3.7). MIE
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significantly reduced the PE maximal tension in diabetic arteries to the same level as those in CS
and CE.
3.3.9 Effects of MIE on the MA Myogenic Tone
The microvasculature regulates blood flow to organs by virtue of myogenic tone
(constriction in response to intraluminal pressure) and therefore ensures smooth blood flow to
organs despite changes in systemic hemodynamics. Increased myogenic tone could indicate an
increase in vascular resistance and a subsequent rise in blood pressure. MA myogenic tone was
assessed over increasing intraluminal pressure (20-120 mmHg). The myogenic tone in DS
arteries was significantly higher compared to the other groups (Figure 3.9). Similar to the
contractile response to PE, MIE significantly reduced the myogenic tone in the DE group,
although it did not reach to the level of the control groups (CS and CE). There was no difference
in the myogenic tone (%) between control groups (CS and CE).
3.3.10 Effects of MIE on NADPH oxidase-1 (NOX-1) Expression
To further investigate other possible mechanisms besides COX metabolites, that may
have contributed to the elevated contractile responses (or decreased ACh responses) in the DS
group, NOX-1 protein expression was measured in MA. NOX-1 expression was slightly
elevated in MA from DS groups, but the difference between DS and the other experimental
groups was not statistically significant (Figure 3.10).
3.3.11 Effects of MIE on the MA and Aortic Wall Thickness
Increased IMT could be an early marker for atherosclerosis (McCloskey et al., 2014).
Adverse MA remodeling in the type-1 and type-2 diabetic models has been reported (Crijns et
al., 1999; Souza-Smith et al., 2011). In the current study, wall thickness was determined to
investigate the effect of diabetes and MIE on resistant MA remodeling. The MA taken from the
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DS group exhibited a significantly higher wall thickness compared to all other groups. However,
the wall thickness of the DE group was comparable to that of the control groups. There was no
difference in the MA wall thickness among CS, CE, and DE groups (Figure 3.11).
To further investigate whether diabetes causes an adverse remodeling of conduit arteries
(i.e., aorta) in the UCD-T2DM model and examine the impact of MIE, we analyzed aortic IMT
by histological staining. Hematoxylin and eosin (H&E) stained aortic sections were investigated
for IMT of the aorta (Figure 3.12). DS aorta showed a significantly greater IMT (132.4±4.9µm)
compared to all other groups. MIE reduced the thickness in the DE aorta to a level comparable
to the control groups. There was no difference in the aortic IMT of CS (108.7±2.5µm), CE
(109.8±2.0µm), and DE (109.9±5.3µm) groups.
3.3.12 Effects of MIE on Aortic Elastin Content
Vascular elastin and collagen content are passive indicators of its stiffness (Wagenseil &
Mecham, 2012). Increased elastin degradation, together with collagen deposition in the intima,
increases the stiffness of the artery. Aortic elastin content was measured by Verhoeff Van
Gieson staining to investigate the impact of MIE on mechanical changes in the aortic wall
structure in diabetes. MIE increased elastin (% to the total area) content in CE (32.0±3.2%)
group compared to all other groups. Although there was no significant difference in CS
(21.9±1.2%), DS (17.3.0±0.7%), and DE (21.8±1.8%) aortic elastin content, the DS group
showed a decreasing trend in aortic elastin content among the groups.
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Figure 3.1 Effects of MIE on metabolic parameters of sedentary and exercise-trained SD (CS, CE)
and diabetic (DS, DE) rats. (A) Body weight (B) Adipose tissue to Body weight ratio (C)
Triglyceride level (D) Blood glucose level (E) HbA1c (%) (F) Insulin level. Values are represented
as mean ± SEM. Each bar represents the values obtained from n=5-7 animals per group. Capped
lines indicate significant differences between two groups (*p<0.05, **p<0.01, ***p<0.001,
****p<0.0001), analyzed by one-way ANOVA followed by Tukey’s post hoc test.
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Table 3.3
Effects of MIE on Metabolic Parameters of Sedentary and Exercise-trained SD (CS, CE) and
Diabetic (DS, DE) Rats
CS

CE

DS

DE

Body Weight (g)

383.3±4.2

366.7±5.1

559.3±30.4*#$

469.3±6.2*#

Adipose Tissue (g)

2.53±0.4

1.37±0.1

5.89±1.4*#$

2.14±0.2

Adipose Tissue/

0.006±0

0.003±0

0.009±0#$

0.004±0

1.35±0.2

1.36±0.1

3.52±0.3*#$

1.54±0.2

111.0±6.4

105.0±6.4

518.0±32.6*#

545.0±14.5*#

4.13±0

4.33±0.1

12.17±0.6*#

12.50±0.2*#

0.74±0.2

0.83±0.2

0.39±0.2*#

0.25±0.0*#

Body Weight (g)
Triglyceride
(mmol/l)
Blood Glucose
(mg/dl)
HbA1c level
Insulin (ng/ml)

Data are expressed as mean ± SEM; n=5-6 rats per group. #p<0.05 (vs. CS), *p<0.05 (vs. CE),
$p<0.05 (vs. DE), analyzed using one-way ANOVA followed by Tukey’s post hoc test.
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Figure 3.2 Relaxation responses to cumulative concentrations of acetylcholine (ACh, 10-8 to 10-5
M) in intact mesenteric arterial rings precontracted with phenylephrine (PE, 2µM) from sedentary
and exercise-trained SD (CS, CE) and diabetic (DS, DE) rats. Data are expressed as mean ± SEM.
n=5-8 animals per group. Parenthesis indicates significant differences between groups (p< 0.05)
analyzed using 2-way ANOVA followed by Tukey’s post hoc test.
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Table 3.4
Sensitivity (pD2: -logEC50), and Maximum Response (Rmax) to ACh in Mesenteric Arteries from
Sedentary and Exercise-trained SD (CS, CE) and Diabetic (DS, DE) Rats
ACh

n

pD2(-logEC50)

Rmax (%)

CS

7

7.40±0.2

98.91±0.6

CE

5

7.22±0.1

98.60±1.0

DS

5

5.80±0.2*#$

59.85±2.2*#$

DE

8

6.72±0.1#

90.74±2.4*#

Data are expressed as mean ± SEM; n=5-8 rats per group. #p<0.05 (vs. CS), *p<0.05 (vs. CE),
$p<0.05 (vs. DE), analyzed using one-way ANOVA followed by Tukey’s post hoc test.
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Figure 3.3 Effects of inhibiting cyclooxygenase (COX), nitric oxide synthase (NOS), small
conductance and intermediated conductance calcium-activated potassium channels (SKca and IKca)
on ACh-induced vasorelaxation in mesenteric arteries taken from sedentary and exercise-trained
SD (CS, CE) and diabetic (DS, DE) rats; (A) CS, (B) CE, (C) DS, (D) DE.
CRC to ACh (10-8 to 10-5 M) was generated in the presence of no inhibitor (No drug) or in the
presence of Indo, Indo+L-NAME (I+L), and Indo+L-NAME+Apamin+TRAM-34 (I+L+A+T) in
mesenteric arterial rings. Indo (indomethacin; 10µM), L-NAME (Nw-nitro-L-arginine methyl
ester; 200µM), Apamin (1µM), TRAM-34; [1-[(2-Chlorophenyl)diphenylmethyl]-1H-pyrazole;
1µM]. * (P<0.05) vs. no drug; # (P<0.05) vs. Indo; $ (P<0.05) vs. Indo+L-NAME, analyzed using
2-way ANOVA with repeated measures followed by Bonferroni post hoc test.

Data are expressed as mean ± SEM; n=5-8 rats per group. Analysis between the group: #p<0.05 (vs. CS), *p<0.05 (vs. CE),
$p<0.05 (vs. DE), analyzed using one-way ANOVA followed by Tukey’s post hoc test. Analysis within the group: ap<0.05
vs. no drug control within each group, bp<0.05 vs. Indo within each group, cp<0.05 vs. Indo+L-NAME, (paired Student’s ttest). ND; not determined.

A comparison of sensitivity (pD2), maximum response (Rmax) and ΔAUC to acetylcholine in the absence (no drug) or in the
presence of Indo, Indo+L-NAME, and Indo+L-NAME+Apamin+TRAM-34in MA rings from sedentary and exercise-trained
SD control (CS, CE) and diabetic (DS, DE) rats. ΔAUC were measured by measuring the area between two curves. ΔAUC of
Indo indicates COX contribution, ΔAUC of Indo+L-NAME indicates NO contribution and, ΔAUC of Indo+LNAME+Apamin+TRAM-34 indicates EDHF-type contribution in ACh-induced vasorelaxation of MA.

Table 3.5
Sensitivity (pD2: -logEC50), Maximum response (Rmax), and Area Under the Curve to ACh in Mesenteric Arteries from
Sedentary and Exercise-trained SD (CS, CE) and Diabetic (DS, DE) Rats
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Figure 3.4 Relaxation responses to cumulative concentrations of SNP (10-9 to 10-5 M) in intact
mesenteric arterial rings precontracted with phenylephrine (PE, 2µM) from sedentary and
exercise-trained SD (CS, CE) and diabetic (DS, DE) rats. Data are expressed as mean ± SEM.
n=5-6 animals per group, analyzed using 2-way ANOVA followed by Tukey’s post hoc test.
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Table 3.6
Sensitivity (pD2: -logEC50), and Maximum Response (Rmax) to SNP in Mesenteric Arteries from
Sedentary and Exercise-trained SD (CS, CE) and Diabetic (DS, DE) Rats
SNP

n

pD2(-logEC50)

Rmax (%)

CS

5

7.23±0.3

89.89±4.9

CE

5

7.38±0.2

96.88±2.1

DS

5

7.36±0.2

91.16±1.2

DE

6

7.08±0.1

87.78±2.0

Data are expressed as mean ± SEM; n=5-6 rats per group. Analyzed by one-way ANOVA
followed by Tukey’s post hoc test.
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Figure 3.5 Western blot analysis of (A) COX-1 (B) COX-2 expression in mesenteric artery (MA)
of sedentary and exercise-trained SD (CS, CE) and diabetic (DS, DE) rats. Protein level were
quantified by densitometry and normalized to corresponding GAPDH. Values are represented as
mean ± SEM.
Each bar represents the values obtained from n=3-4 animals per group.
Representative bands of target and housekeeping protein (GAPDH) were shown from the same
membranes. Capped lines indicate significant differences between two groups (*p<0.05,
**p<0.01), as analyzed by one-way ANOVA followed by Tukey’s post hoc test.
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Figure 3.6 Western blot analysis of eNOS expression in mesenteric artery (MA) of sedentary and
exercise-trained SD (CS, CE) and diabetic (DS, DE) rats. Protein level were quantified by
densitometry and normalized to corresponding GAPDH. Values are represented as mean ± SEM.
Each bar represents the values obtained from n=4-5 animals per group. Representative bands of
target and housekeeping protein (GAPDH) were shown from the same membranes. Capped lines
indicate significant differences between two groups (**p<0.01, ***p<0.001, ****p<0.0001), as
analyzed by one-way ANOVA followed by Tukey’s post hoc test.
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Figure 3.7 Western blot analysis of (A) IKCa (KCa3.1) (B) SKCa (KCa2.3) expression in mesenteric
artery (MA) of sedentary and exercise-trained SD (CS, CE) and diabetic (DS, DE) rats. Protein
level were quantified by densitometry and normalized to corresponding GAPDH. Values are
represented as mean ± SEM. Each bar represents the values obtained from n=4-5 animals per
group. Representative bands of target and housekeeping protein (GAPDH) were shown from the
same membranes. Capped lines indicate significant differences between two groups (*p<0.05), as
analyzed by one-way ANOVA followed by Tukey’s post hoc test. Figure B) top right section is
showing comparison of only diabetic groups (DS vs. DE) which was analyzed by Student’s
unpaired t-test.
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Figure 3.8 Concentration response curve to cumulative concentrations of phenylephrine (PE, 10-8
to 10-5 M) in intact mesenteric arterial rings from sedentary and exercise-trained SD (CS, CE) and
diabetic (DS, DE) rats. Data are expressed as mean ± SEM. n=5-6 animals per group. #p<0.05
(vs. CS), *p<0.05 (vs. CE), $p<0.05 (vs. DE), analyzed by using 2-way ANOVA followed by
Tukey’s post hoc test.
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Table 3.7
Sensitivity (pD2: -logEC50), and Maximum Tension (Tensionmax) to PE in Mesenteric Arteries
from Sedentary and Exercise-trained SD (CS, CE) and Diabetic (DS, DE) Rats
PE

n

pD2(-logEC50)

Tensionmax

CS

6

6.49±0.16

15.45±1.24

CE

5

6.46±0.12

12.23±0.54

DS

5

6.46±0.18

23.03±2.74*#$

DE

5

6.41±0.11

16.20±1.18

Data are expressed as mean ± SEM; n=5-6 rats per group. #p<0.05 (vs. CS), *p<0.05 (vs. CE),
$p<0.05 (vs. DE), analyzed using one-way ANOVA followed by Tukey’s post hoc test.
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Figure 3.9 Myogenic tone (%) at different intraluminal pressure in intact mesenteric arterial rings
from sedentary and exercise-trained SD (CS, CE) and diabetic (DS, DE) rats. Data are expressed
as mean ± SEM. n=5-8 animals per group. #p<0.05 (vs. CS), *p<0.05 (vs. CE), $p<0.05 (vs. DE),
analyzed using 2-way ANOVA followed by Tukey’s post hoc test.
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Figure 3.10 Western blot analysis of NOX-1 expression in mesenteric artery (MA) of sedentary
and exercise-trained SD (CS, CE) and diabetic (DS, DE) rats. Protein levels were quantified by
densitometry and normalized to corresponding GAPDH. Values are represented as mean ± SEM.
Each bar represents the values obtained from n=3-4 animals per group. Representative bands of
target and housekeeping protein (GAPDH) were shown from the same membranes and analyzed
by one-way ANOVA followed by Tukey’s post hoc test.
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Figure 3.11 Wall thickness at different intraluminal pressure in intact mesenteric arterial rings
from sedentary and exercise-trained SD (CS, CE) and diabetic (DS, DE) rats. Data are expressed
as mean ± SEM. n=5-8 animals per group. #p<0.05 (vs. CS), *p<0.05 (vs. CE), $p<0.05 (vs. DE),
analyzed using 2-way ANOVA followed by Tukey’s post hoc test.
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Figure 3.12 Effects MIE on aortic intima medial thickness. A) Hematoxylin and eosin (H&E)
stained sections of aorta from sedentary and exercise-trained SD (CS, CE) and diabetic (DS, DE)
rats. B) Comparison of aortic intima medial thickness. Each bar represents the values obtained
from n=4 animals per group. Capped lines indicate significant differences between two groups
(**p<0.01,), analyzed by one-way ANOVA followed by Tukey’s post hoc test.
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Figure 3.13 Effects MIE on aortic elastin content. A) Verhoeff and Van Gieson-stained sections
of aorta from sedentary and exercise-trained SD (CS, CE) and diabetic (DS, DE) rats. Elastin
fibers are stained as black lines in the intima. B) Comparison of aortic elastin content (% to total
area). Each bar represents the values obtained from n=4 animals per group. Capped lines indicate
significant differences between two groups (*p<0.05, **p<0.01, ***p<0.001), analyzed by oneway ANOVA followed by Tukey’s post hoc test.
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3.4 Discussion
To the best of our knowledge, this is the first study that measured the effects of MIE on
vascular function and wall structure of the UCD-T2DM model. Here, we demonstrated an
impairment of ACh-induced vasorelaxation in MA from DS rats. Our data also showed that the
impaired vasorelaxation of DS arteries could be associated with the enhanced vasocontractile
contribution of COX and/or loss of EDHF-type relaxation. Intriguingly, MIE improved
vasorelaxation in MA, possibly due to a shift from contractile COX to NO- and EDHF-type
relaxation in the diabetic group. Furthermore, MA from the DS group exhibited a higher
contractile response and myogenic tone than in arteries from control rats. Our data also showed
that exercise training reduced the PE-induced contractile response and myogenic tone of MA in
diabetic rats. Additionally, we demonstrated that wall thickness in both small and large arteries
were significantly greater in the DS group, and MIE reduced the wall thickness of diabetic
arteries to the same level as controls.
Lack of physical activity was reported to be correlated with obesity (Ladabaum et al.,
2014). On the other hand, according to the American College of Sports Medicine and American
Diabetes Association, the recommended physical activity (150 mins/week) may help to lose
weight. However, 60mins/day of physical activity may be required when relying on exercise
alone to lose weight (Colberg et al., 2010). In the current study, eight weeks (1hr/day,
5days/week) of MIE reduced body weight, abdominal adiposity, and triglyceride level in the
diabetic group (DE) compared to their sedentary counterpart (DS). Previously, changes in
triglyceride levels were observed in both Zucker Diabetic Fatty (ZDF) rats and patients of
coronary heart diseases after eight weeks of aerobic exercise training (D. Ito et al., 2015; Y.
Wang et al., 2019). MIE did not alter the plasma insulin, blood glucose, and HbA1c level in

113
either control or diabetic groups. In agreement with our observation, a previous report suggested
insulin secretion of T2D patients did not change after a single bout of MIE (Knudsen et al.,
2015). Additionally, clinical trial from the US diabetes prevention program indicated MIE with
caloric restriction could reduce the incidence of diabetes in impaired fasting glucose individuals
up to 58% compared to 31% of metformin treated group (Knowler et al., 2002). We did not
implement caloric restriction in our experimental groups since the focus of our study was to
investigate the mechanism of MIE-induced changes in MA structure and function in diabetes.
Still, we observed a reduction in metabolic risk factors such as body weight, abdominal
adiposity, and triglyceride level in the exercise-trained diabetic group. However, MIE did not
significantly improve the glycemic or insulin status of the diabetic group.
Endothelial dysfunction and impaired EDV is a hallmark of CVD in diabetes. Several
studies, including ours, have reported endothelial dysfunction and impaired EDV in diabetes (De
Vriese et al., 2000; Moien-Afshari et al., 2008; Shaligram et al., 2020; Takenouchi et al., 2010;
Zhang et al., 2012). In addition, the protective effects of exercise against vascular dysfunction in
diabetes are also reported in a number of studies (Qiu et al., 2018). In the current study, the
sedentary UCD-T2DM rats showed a significantly impaired vasorelaxation of MA compared to
control groups. MIE improved the vasorelaxation without changing the glycemic status,
suggesting vascular dysfunction in diabetes could be prevented by MIE, independent of
hyperglycemic status. Similarly, previous report has shown that MIE could improve the aortic
function of db/db mice without changing body weight or hyperglycemic condition (MoienAfshari et al., 2008). Furthermore, Sakamoto et al. reported exercise training but not food
restriction prevents endothelial dysfunction in type-2 diabetic OLETF rat aorta, indicating
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exercise as the major physiological stimulus required for improving vascular function in diabetes
(Sakamoto et al., 1998).
Impaired EDV in diabetes may arise from several mechanisms: decreased production of
EDRFs and increased production of endothelium-derived contractile factors (EDCF), enhanced
inactivation of EDRFs, impaired diffusion of EDRF to underlying smooth muscle, and reduced
sensitivity of the smooth muscle to EDRFs (De Vriese et al., 2000). The contribution of EDRFs
to EDV may change depending on the vascular beds. Although NO is considered the major
EDRF in conduit arteries, in small resistant arteries, EDHF plays a significant role in EDV
(Félétou et al., 2011). Previous reports from our laboratory using type-1 and type-2 diabetic rats
demonstrated that EDHF-type relaxation was diminished, whereas the dependency on NOmediated relaxation was enhanced in diabetic MA (Shaligram et al., 2020; Zhang et al., 2012).
Similarly, in the current study, we observed a loss of EDHF-type relaxation with an increased
dependency on NO-mediated relaxation in the MA of the DS group. Increased NO contribution
may be explained by elevated eNOS expression (Figure 3.6) observed in DS and DE arteries.
The elevated NO contribution in diabetic MA could be a compensatory mechanism for loss of
EDHF-type relaxation. Previous research suggests a negative feedback relationship exists
between NO and EDHF. NO attenuated release of EDHF in rabbit carotid and porcine coronary
arteries (Bauersachs et al., 1996; Brandes et al., 2000). On the other hand, an augmented EDHF
response was reported to compensate for reduced NO-mediated relaxation in diabetic arteries
(Garland et al., 1995; Malakul et al., 2008). Additionally, our study was in agreement with
previous reports which described increased eNOS expression in the heart and aorta of type-2
diabetic Goto- Kakizaki rat model (Bitar et al., 2005; Desrois et al., 2010). Despite the higher
relative importance of NO, vascular relaxation was signiﬁcantly impaired in the sedentary
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diabetic model, possibly due to of loss of EDHF. Furthermore, any increase in NO has the
potential for free radical-mediated damage, particularly under conditions of oxidative stress in
diabetes, where peroxynitrite is formed more easily (Zhang et al., 2012).
Although NO is generally considered the principal mediator of EDV, it has become clear
that EDHF is also an important contributor to EDV, especially in small arteries like MA. The
contribution of EDHF on vasorelaxation and its identity could vary based on vascular beds under
question (Leo et al., 2011). Tomioka et al. reported EDHF contribution on EDV is inversely
proportional to the vessel diameter (Tomioka et al., 1999). On the other hand, the chemical
identity of EDHF while remains debated, but increasing report suggests the involvement of SKCa
and IKCa channels in the endothelium-derived hyperpolarization of different arteries (Brähler et
al., 2009; Doughty et al., 1999). The classical EDHF pathway involves an agonist-induced
increase in cytosolic Ca2+ concentration, followed by the opening of SKCa and IKCa. Activation
of these KCa channels subsequently hyperpolarize VSMC via activation of Na+/K+-ATPase, Kir,
and BKCa channel or through myoendothelial gap junctions (Edwards et al., 1998; Parkington et
al., 2002; Sandow Shaun L. et al., 2002).
Altered EDHF-mediated relaxation was reported in pathological conditions such as
hypertension, atherosclerosis, and diabetes (Félétou & Vanhoutte, 2004). Specifically, in
diabetic animals, both increased and decreased EDHF-mediated responses were reported (Gao et
al., 2011). Nevertheless, previous studies, including ours, reported attenuated EDHF mediated
responses in mesenteric arteries from both type-1 and type-2 diabetic rats (Makino et al., 2000;
Shaligram et al., 2020; Zhang et al., 2012). In agreement with the previous reports showing
impaired EDHF-relaxation, our current study has demonstrated a diminished EDHF-type
relaxation in MA of DS rats. Intriguingly, MIE prevented the loss of EDHF-mediated relaxation
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in male UCD-T2DM rats (DE vs. DS, Figure 3.3 C-D). Similarly, Minami et al. reported nine
weeks of exercise training improved EDHF contribution in MA of type-2 diabetic OLETF rats
(Minami et al., 2002). Next, we investigated whether altered EDHF relaxation response was
related to a change in the KCa (IKCa and SKCa) level of MA. In the current study, when IKCa
expression level was investigated, both diabetic groups, regardless of exercise training, showed a
decreasing trend of IKCa protein level in MA compared to their respective controls. However,
the difference did not reach to the significant level (Figure 3.7A). On the other hand, when SKCa
expression was measured in MA, the DS group showed a significantly decreased in SKCa level
compared to CS and CE (0.7 and 0.8-fold decreased respectively). When only diabetic SKCa
protein level was compared (DS vs. DE, t-test), the DE group showed an enhanced SKCa level
(0.3-fold increase) in MA compared to DS (Figure 3.7B). This data may suggest that the
decrease of EDHF-type relaxation observed in the DS group, in part, could be due to lower
expression of SKCa channel in MA of DS group. Furthermore, the pattern of KCa expression
observed in the current study was in a similar line with our recent report on the KCa expression in
UCD-T2DM animals (Shaligram et al., 2020).
In addition to a possible role of altered EDRF, other mechanisms that may explain MA
dysfunction in diabetes could also result from a decreased sensitivity of smooth muscle to NO or
an enhanced contractile response to contractile agents such as PE or endothelin-1 (ET-1).
Previous studies have reported impaired EDV in the presence of preserved endotheliumindependent relaxation (Leo et al., 2010; J. C. Li et al., 2021; Takenouchi et al., 2010).
Similarly, in the current study, we did not observe a difference in SNP (a NO donor) induced
relaxation in any of the groups after blocking the EDRF contribution with a combination of
Indo+L-NAME+Apamin+TRAM-34. This may further emphasize that endothelial dysfunction,
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but not reduced smooth muscle sensitivity to NO in the DS group may be responsible for reduced
EDV in this group. In contrast, reports of impaired SNP-induced relaxation in diabetes are also
available (Brown et al., 2001; Csanyi et al., 2007). Clearly, further studies are required to
elucidate the relationship between diabetes and vascular smooth muscle sensitivity to NO.
To further investigate whether an enhanced contractile response was responsible for the
impaired vascular function in the DS group, we measured PE-induced contractile response in
MA. Conflicting data about diabetes and its effects on the contractile response of the vasculature
are available with reports showing decreased, no change, and increased contractile response
(Park et al., 2011; Matsumoto et al., 2008; Guo et al., 2005). Previous studies which reported an
increase in contractile response of vessels from diabetic rats, mentioned the contribution of
COX-1&2 and oxidative stress leading to hypersensitivity of smooth muscle (Shi & Vanhoutte,
2008; Guo et al., 2005; Santiago et al., 2016). In the current study, we investigated
vasoconstriction responses to an α1 adrenoceptor agonist (PE) in MA from control and diabetic
rats. PE-induced vasoconstriction response was enhanced in the MA of DS groups compared to
DE and control groups, which could be due to an increase in contractile metabolites in DS
arteries (Figure 3.8, Table 3.7). Furthermore, unlike in the DS group, inhibition of COX with
Indo had no effect on the ACh response of the DE group, suggesting that MIE may reduce the
contractile COX activity in MA of male UCD-T2DM rats (DE vs. DS, Figure 3.3 C-D). Both
COX-1 and COX-2 may produce metabolites that regulate vascular tone. While COX-1 is
expressed constitutively in almost all tissues, COX-2 is often the inducible isoform and
expressed in inflammatory sites. Prostacyclin (PGI2), the major vasodilatory product of the COX
pathway, was reported to be generated by COX-1 but not COX-2 (Kirkby et al., 2012).
However, paradoxically PGI2 can also cause contraction of arteries due to dysfunction of its
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preferential PGI2 receptor (IP). In spontaneously hypertensive rat aorta, PGI2 acts as an EDCF
due to dysfunction of IP receptors (Gomez et al., 2008). Despite reports of both COX isoforms
in endothelium-dependent contraction, increasing reports suggest in pathological conditions such
as obesity, oxidative stress and hypertension, COX-2 could be a major source for EDCF. It was
reported that COX-2 contributes to cardiac oxidative stress and coronary vasoconstriction in
obese Zucker rats (Santiago et al., 2016). In hypertension, up-regulation of COX-2 expression
and NOX-mediated generation of reactive oxygen species (ROS) and the subsequent activation
of p38 MAPK favors the emergence of the amplified endothelium-dependent contractions
(Félétou et al., 2011). In the current study, we did not measure the COX-derived prostanoids or
measure vasoconstriction to PE in the presence of selective COX inhibitors. Therefore, we
cannot define the role of specific COX isoform on vasoconstriction of MA. Nevertheless, we
observed an increase in both COX-1&2 protein expression in DS arteries compared to DE,
suggesting an enhanced COX derived contractile prostanoids, at least in part, could be a mediator
of higher contractile response in the DS group.
Pressure-induced constriction, also known as myogenic tone, is a major regulator of
blood flow and an inherent property of resistant arteries. In response to physiological pressures,
myogenic arteries constrict, and at lower physiological pressure, the arteries dilate, thereby
autoregulating the blood flow to organs and tissues (Johnson, 1986). Myogenic tone is also
thought to be a critical contributor of vascular resistance and hence blood pressure (Meininger &
Davis, 1992). Enhanced myogenic tone, therefore, could lead to elevation of systemic blood
pressure in T2D (Bagi et al., 2005). In the current study, we demonstrated that pressure-induced
myogenic constriction in the MA of the DS group was enhanced, and MIE significantly
decreased the tone in DE, although it did not reach to the level of control groups (Figure 3.9).
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Similar reports of enhanced myogenic tone in mesenteric, cerebral, and skeletal muscle arteries
were reported in T2D rodent models (Lagaud et al., 2001; Jarajapu et al., 2008; Frisbee et al.,
2002). In contrast, myogenic tone was also reported to decrease in the ophthalmic artery of type2 diabetic BBZDR/Wor rat (I. Ito et al., 2006), suggesting pressure-dependent autoregulation of
vascular tone could be affected differently in various resistant vascular beds in T2D. In the
current study, increased myogenic tone in DS could be due to enhanced contractile prostanoids
generated by COXs. In agreement with our results, previous reports suggest increase in one or
more vasoconstricting prostanoids could lead to an increase in myogenic tone in diabetes, and
COX-2 could be a major player contributing to this increased arterial tone (Bagi et al., 2005;
Lagaud et al., 2001).
Superoxide generation in diabetes also may play an important role in activating
endothelium-derived contractile factors (Shi et al., 2007; Shi & Vanhoutte, 2008; Vanhoutte &
Tang, 2008). NO scavenging by superoxide anion could decrease NO bioavailability and favor
endothelium-dependent contraction (Rubanyi et al., 1986). NOXs are the major sources of
reactive oxygen species in vasculature. NOX-1 and NOX-2 are important sources of superoxide
in MA (Y. Li & Pagano, 2017). When we measured NOX-1 expression in the MA, although DS
arteries showed a greater expression compared to DE and control group, it did not reach to the
significance level (possibly due to the lower n number). However, NOX-1 is not the only
isoform in MA, and the presence of NOX-1, NOX-2, and NOX-4 was reported in MA (Y. Li &
Pagano, 2017). In the current study, we tried to measure NOX-4 beside NOX-1. However, no
detectable bands were observed, possibly due to our experimental limitation (unable to load
higher protein amount and/or lower sensitivity of the antibody). Although we did not measure
the other isoforms, previous reports, including ours suggest, increased expression of NOX-1,
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NOX-2, and NOX-4 in the diabetic aorta and mesenteric arteries (Akther et al., 2021; Galán et
al., 2012; Shaligram et al., 2020). In addition, in our recent report we have demonstrated that
ROS generation was enhanced in primary aortic endothelial cell from UCD-T2DM rats (Akther
et al., 2021). Therefore, NOX isoforms could increase oxidative stress in diabetic MA. Clearly,
further studies are required to elucidate the role of individual NOX isoform on MA function in
diabetes.
The diabetes-associated vascular diseases manifest endothelial dysfunction followed by
structural changes of large and small arteries (Spinetti et al., 2008). IMT is considered a
surrogate marker of atherosclerosis in pathogenic conditions (de Groot et al., 2004). In small
resistant MA from db/db mice, increased outward remodeling was characterized by an enhanced
cross-sectional area and thus suggesting an increase in wall thickness in diabetic arteries (SouzaSmith et al., 2011). Increased wall thickness, together with increased collagen deposition and
change in the elastic lamina, were associated with increased stiffness in MA from aged rats
(Briones et al., 2007). In the current study, we demonstrated that diabetes significantly increased
both the MA and aortic wall thickness in the DS group. However, the exercise training
prevented the increase in wall thickness in diabetic group and the MA and aortic wall thickness
in DE group was similar to control groups (CS and CE) (Figure 3.11 and 3.12). In agreement
with our observation, aerobic exercise reduced MA wall thickness (media/lumen ratio) in the
hypertensive SHR model, (Xiong et al., 2021). Additionally, a previous report also suggests
exercise decreases arterial wall thickening in human subjects with existing CVD and
cardiovascular risk factors (Thijssen et al., 2012).
Arterial stiffness is a critical functional and structural property of the vessel wall in
diabetes. Stiffening predominantly affects the aorta and, to a lesser degree, the peripheral
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muscular arteries. A host of indices have been introduced to quantify arterial stiffness. Elastin
and collagen are two key elements in vascular remodeling, and they can determine the stiffness
passively (Wagenseil & Mecham, 2012). Arterial elastin degradation is often accompanied by
increased deposition of collagen in the intima, leading to arterial stiffening and thickening of
intima-media (Adeva-Andany et al., 2021). In the current study, the CE group had significantly
higher aortic elastin content compared to all other groups, which may indicate a possibility of
improved elasticity and reduced stiffness of the aorta in this group. In agreement with our
observation, exercise training increased elastin content in the aorta of Wister Kyoto and SD rats
(Matsuda et al., 1993; Souza et al., 2017). On the other hand, although DS aortas showed a
lower level of elastin compared to DE, the difference did not reach to the significant level. In the
present study, we did not measure aortic stiffness by pulse wave velocity and/or measure
collagen content. Therefore, we are unable to explain whether aortic stiffness is increased in
UCD-T2DM rats. However, previous reports suggest diabetes may enhance collagen content in
the aorta of T2D rodents and humans and, therefore, increase aortic stiffness (Katz et al., 2011;
X. Wang et al., 2006). In agreement with this theory, previous studies which alternatively
measured aortic stiffness by pulse wave velocity in T2D patients, reported increased aortic
stiffness (Dec-Gilowska et al., 2020; Mansour et al., 2013).
In conclusion, this study represents the first report showing MIE improves MA function
possibly by causing a shift from contractile COX to NO-and EDHF- type relaxation in UCDT2DM male rats. Furthermore, our data suggest MIE may improve EDV by decreasing COX
expression and possibly reducing vasocontractile prostanoids activity in diabetic MA. An
intriguing observation was that MIE reduced the loss of EDHF-type relaxation in diabetic MA,
possibly by enhancing SKCa contribution on EDHF-type relaxation. Additionally, MIE reduced

122
myogenic tone, and the contractile response of MA arteries of the diabetic group, which could
have in part contributed to the enhanced vasorelaxation observed in exercise-trained diabetic
group. Furthermore, we demonstrated that MIE prevented the increase in wall thickness/IMT in
large and small arteries, suggesting that MIE possibly also reduces adverse remodeling of
arteries in UCD-T2DM animals. Clearly, additional studies will be required to understand the
mechanisms of exercise-mediated changes in vascular endothelial function and wall properties in
diabetes.
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CHAPTER 4: CONCLUSION, FUTURE DIRECTIONS AND LIMITATIONS

Cardiovascular diseases (CVD) remain the leading cause of death in diabetic patients,
regardless of the recent advances in cardiovascular medicine and technology. Despite the
existence of a number of studies on the underlying mechanisms of vascular dysfunction in
diabetes, the effect of sex hormones and exercise on the diabetic vasculature remained poorly
understood. The main objectives of the studies in this dissertation were to investigate the
impacts of 17-β estradiol (E2) and moderate-intensity exercise (MIE) on mesenteric arterial (MA)
function in the University of California Davis type-2 diabetes mellitus (UCD-T2DM) Rats.
In the first study outlined in this dissertation, we demonstrated that acetylcholine (ACh)induced vasorelaxation was impaired in MA of ovariectomized (OVX) prediabetic UCD-T2DM
Rats. E2 replacement improved MA relaxation in OVX prediabetic group to a similar level to
that in control groups. Inhibition of cyclooxygenase (COX) by indomethacin did not
significantly affect the vascular responses in any groups, suggesting a minor role of COX
metabolites in MA relaxation in the experimental groups. Inhibition of nitric oxide (NO)
synthase (NOS) by L-NAME reduced vasorelaxation to ACh in control groups, but it did not
completely abolish the vasorelaxation. We also showed that in control (healthy) groups, both
NO and endothelium-derived hyperpolarizing factor (EDHF)-type relaxation were dominant in
the MA relaxation of placebo and E2 treated rats. However, in prediabetic groups, L-NAME
completely abolished the vasorelaxation, regardless of E2 treatment, suggesting a relative shift
from EDHF-type relaxation to only NO-mediated relaxation in these groups. Furthermore, the
sensitivity of MA to NO was significantly impaired in OVX prediabetic group, but E2 treatment
enhanced the MA sensitivity to NO. Lastly, E2 treated OVX prediabetic rats exhibited improved
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insulin signaling and glucose uptake in skeletal muscle. Overall, our data suggest that a greater
vasorelaxation in the E2 treated OVX prediabetic group could be, in part, attributed to the
elevated role of NO or improved sensitivity of MA to NO in this group.
We previously reported that MA from diabetic female rats showed a greater extent of
impairment compared to that in diabetic males despite having a relatively preserved vascular
function at the early prediabetic state. However, when females become diabetic, they exhibit a
greater endothelial dysfunction than males (Shaligram et al., 2020). Although the results of the
current study are in agreement with our previous report demonstrating a possible protective
effect of female sex hormones in the MA function at prediabetic state, additional studies are
needed to establish the specific role of E2 in the progression of vascular dysfunction in the
diabetic state.
In the second study of this dissertation, we have demonstrated that ACh-induced MA
vasorelaxation was impaired in the diabetic sedentary (DS) group. However, MIE improved the
vasorelaxation of UCD-T2DM male rats, possibly by causing a shift from the contractile COX
action to NO and EDHF-type relaxation. Furthermore, our data suggested that MIE may
decrease vasocontractile COX activity and elevate EDHF-type relaxation, possibly by reducing
the expression of COX isoforms and increasing expression of small conductance calciumactivated potassium channel (SKCa) in diabetic MA. Additionally, MIE reduced contractile
response and myogenic tone in diabetic MA, and it decreased the wall thickness of both large
and small arteries. Although these results suggest exercise training alleviates vascular
dysfunction in UCD-T2DM male rats, we did not measure the MIE effects in female diabetic
rats. Given that sex differences play an important role in cardiovascular physiology, additional
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studies are needed to establish the specific role of MIE on vascular dysfunction in UCD-T2DM
female rats and its underlying mechanisms.
A number of reports, including ours, suggest that EDHF, a significant contributor of
endothelium-dependent vasorelaxation (EDV) in MA, is lost in diabetes (Leo et al., 2011;
Shaligram et al., 2020; Zhang et al., 2012). Accordingly, our study suggests that EDHF-type
relaxation is significantly higher in healthy rat arteries, but it is lost in both prediabetic and
diabetic states. Loss of EDHF-mediated vasorelaxation in diabetes may result from reduced
expression and/or function of potassium channels (i.e., small and intermediate conductance
calcium-activated potassium channels; SKCa and IKCa) that control hyperpolarization of
endothelial cells and subsequently underlying smooth muscle. Other factors include
irregularities of myoendothelial gap junction function and reduced synthesis of hyperpolarization
factors such as epoxyeicosatrienoic acids (EET). However, there is a common acceptance of
SKCa and IKCa as the major contributors to the classical EDHF pathway. In our second study, we
observed an elevated contribution of EDHF-type relaxation in exercise-trained diabetic MA
compared to the sedentary diabetic group. Interestingly, we observed an increase in SKCa
channel expression in MA of DE compared to that in DS group. These data suggest that the
observed elevated EDHF-type relaxation in MA of DE may be attributed to the increased SKCa
channel expression in this group. Further studies are required to elucidate the role of these
channels in controlling EDHF-mediated vasorelaxation in health and diabetes. Understanding
the impact of exercise on these channels may bring forward new therapeutic strategies to treat
diabetes-induced microvascular disease.
Limitations
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1) Third-order resistant MA with a diameter ranging from 200-350µm were used in our
studies. Although this artery represent resistance arteries, it cannot completely explain
complications of other resistance arteries such as renal arteries. Overall, the effects of 17-β
estradiol or MIE could vary depending on the vascular bed (Padilla et al., 2011; Tostes et al.,
2003).
2) In addition to estrogen, ovariectomy may also alter the plasma concentration of other
hormones and other factors such as progesterone, follicle-stimulating hormone (FSH), and
luteinizing hormone (LH) (Yen & Tsai, 1971). Such changes can also affect arterial response to
vasodilator. Our first study does not rule out this possibility. However, ‘E2 replacement in
ovariectomized rats mimics a ‘female’ response’ and is, therefore, an argument against a
significant role for other factors involved in the modulation of female response. In addition,
previous studies, including ours, have also used E2 replacement to investigate the female-specific
responses of the vasculature (Rahimian et al., 1997; Stice et al., 2009). Therefore, we believe
our interpretation and conclusion drawn from the E2 replacement study to record female-specific
vascular function is reasonable.
3) Whole mesenteric arteries containing endothelial and smooth muscle cells were
subjected to Western blot analysis. Therefore, the expression of COX, SKCa, and IKCa in the
mesenteric wall could not be attributed explicitly to either smooth muscle or the endothelial
layer.
4) It is important to note that we did not directly measure the hyperpolarization of smooth
muscle in the current study. However, the sensitivity of Indo+L-NAME resistant relaxation of
control groups to a combination of specific potassium channel inhibitors (apamin and TRAM-34)
are characteristic for EDHF-mediated responses.
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5) The aerobic exercise intensity was not set based on the peak oxygen consumption
(VO2max) in individual rats. Exercise at which a subject uses 50-65% of VO2max may be
considered moderate-intensity exercise. Our treadmill setup was not capable of measuring
VO2max, and thus we set up the intensity/treadmill speed following a thorough review of the
literature. In our study, the obese diabetic rats likely had a different VO2max due to their
increased weight. Therefore, we cannot rule out some slight variation in exercise stimulus
gained by diabetic and control groups. However, the variation was possibly negligible as both
diabetic and control could complete the 1-hour session with little stimulus.
6) The exercise-trained groups were subjected to forced exercise training with a low
electrical stimulus when they stopped running. The number of electrical stimuli was greater in
the acclimation period and gradually became less frequent over the 1st week of training.
Eventually, the electric shock was turned off from 2nd-3rd week to reduce the effect of
inflammatory stimulus. Rats were given a gentle tap on their back when they stopped running.
Although we cannot rule out that the exercise-trained groups received a higher inflammatory
stimulus from the electric shock at the early stage of training than the sedentary group, the effect
might have been negligible due to the reduction of electrical stimuli to a minimum.
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